Advanced Search (OLGA)

Gene: SIRPA (signal regulatory protein alpha) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

SIRPA

Name:

signal regulatory protein alpha

RGD ID:

736759

HGNC Page

HGNC:9662

Description:

Enables cell-cell adhesion mediator activity and protein antigen binding activity. Involved in several processes, including cellular response to interleukin-12; positive regulation of reactive oxygen species metabolic process; and regulation of cytokine production. Located in cell surface and plasma membrane.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

BIT; brain-immunoglobulin-like molecule with tyrosine-based activation motifs; CD172 antigen-like family member A; CD172A; inhibitory receptor SHPS-1; macrophage fusion receptor; MFR; MYD-1; myd-1 antigen; P84; protein tyrosine phosphatase, non-receptor type substrate 1; PTPNS1; SHP substrate-1; SHPS-1; SHPS1; signal regulatory protein, alpha type 1; signal-regulatory protein alpha; SIRP; SIRP-ALPHA-1; SIRPalpha; SIRPalpha2; tyrosine phosphatase SHP substrate 1; tyrosine-protein phosphatase non-receptor type substrate 1

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Related Pseudogenes:

SIRPAP1

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	20	1,894,167 - 1,940,592 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	20	1,894,167 - 1,940,592 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	20	1,874,813 - 1,921,238 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	20	1,822,813 - 1,868,540 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	20	1,823,424 - 1,868,535	NCBI
Celera	20	1,938,791 - 1,984,521 (+)	NCBI		Celera
Cytogenetic Map	20	p13	NCBI
HuRef	20	1,824,406 - 1,870,408 (+)	NCBI		HuRef
CHM1_1	20	1,875,015 - 1,920,758 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	20	1,924,358 - 1,970,769 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SIRPA	Human	pre-malignant neoplasm		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:21472284

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SIRPA	Human	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:10243	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SIRPA mRNA	CTD	PMID:36331819
SIRPA	Human	1,1-dichloroethene	increases expression	ISO	RGD:10243	6480464	vinylidene chloride results in increased expression of SIRPA mRNA	CTD	PMID:26682919
SIRPA	Human	1,2-dimethylhydrazine	increases expression	ISO	RGD:10243	6480464	1,2-Dimethylhydrazine results in increased expression of SIRPA mRNA	CTD	PMID:22206623
SIRPA	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of SIRPA mRNA; [Estradiol co-treated with more ...	CTD	PMID:20660070\|PMID:22217510\|PMID:30165855
SIRPA	Human	17beta-estradiol	increases expression	ISO	RGD:10243	6480464	Estradiol results in increased expression of SIRPA mRNA	CTD	PMID:39298647
SIRPA	Human	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		6480464	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SIRPA mRNA]	CTD	PMID:11007951
SIRPA	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10243	6480464	Tetrachlorodibenzodioxin affects the expression of SIRPA mRNA	CTD	PMID:24680724\|PMID:26377647
SIRPA	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		6480464	Tetrachlorodibenzodioxin affects the expression of SIRPA mRNA	CTD	PMID:22298810\|PMID:22574217
SIRPA	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:3449	6480464	Tetrachlorodibenzodioxin affects the expression of SIRPA mRNA	CTD	PMID:22298810\|PMID:34747641
SIRPA	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		6480464	Tetrachlorodibenzodioxin results in decreased expression of SIRPA mRNA	CTD	PMID:11007951
SIRPA	Human	2,4-dinitrotoluene	affects expression	ISO	RGD:3449	6480464	2,4-dinitrotoluene affects the expression of SIRPA mRNA	CTD	PMID:21346803
SIRPA	Human	3-chloropropane-1,2-diol	increases expression	ISO	RGD:3449	6480464	alpha-Chlorohydrin results in increased expression of SIRPA mRNA	CTD	PMID:28522335
SIRPA	Human	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:10243	6480464	bisphenol S results in decreased expression of SIRPA mRNA	CTD	PMID:39298647
SIRPA	Human	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:10243	6480464	Fenretinide results in decreased expression of SIRPA mRNA	CTD	PMID:28973697
SIRPA	Human	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:10243	6480464	4-vinyl-1-cyclohexene dioxide affects the expression of SIRPA mRNA	CTD	PMID:20829426
SIRPA	Human	aflatoxin B1	decreases methylation	EXP		6480464	Aflatoxin B1 results in decreased methylation of SIRPA gene	CTD	PMID:27153756
SIRPA	Human	Aflatoxin B2 alpha	increases methylation	EXP		6480464	aflatoxin B2 results in increased methylation of SIRPA intron	CTD	PMID:30157460
SIRPA	Human	all-trans-retinoic acid	increases expression	EXP		6480464	Tretinoin results in increased expression of SIRPA mRNA	CTD	PMID:15894607\|PMID:33167477
SIRPA	Human	all-trans-retinoic acid	multiple interactions	EXP		6480464	[Tretinoin co-treated with arsenic trioxide] results in increased expression of SIRPA mRNA	CTD	PMID:15894607
SIRPA	Human	ammonium chloride	affects expression	ISO	RGD:3449	6480464	Ammonium Chloride affects the expression of SIRPA mRNA	CTD	PMID:16483693
SIRPA	Human	antirheumatic drug	decreases expression	EXP		6480464	Antirheumatic Agents results in decreased expression of SIRPA mRNA	CTD	PMID:24449571
SIRPA	Human	aristolochic acid A	decreases expression	EXP		6480464	aristolochic acid I results in decreased expression of SIRPA mRNA	CTD	PMID:33212167
SIRPA	Human	arsenite(3-)	increases methylation	EXP		6480464	arsenite results in increased methylation of SIRPA promoter	CTD	PMID:23974009
SIRPA	Human	arsenous acid	increases expression	EXP		6480464	Arsenic Trioxide results in increased expression of SIRPA mRNA	CTD	PMID:27829220
SIRPA	Human	arsenous acid	multiple interactions	EXP		6480464	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SIRPA mRNA	CTD	PMID:15894607
SIRPA	Human	atrazine	decreases expression	EXP		6480464	Atrazine results in decreased expression of SIRPA mRNA	CTD	PMID:22378314
SIRPA	Human	benzene	increases expression	EXP		6480464	Benzene results in increased expression of SIRPA mRNA	CTD	PMID:19162166
SIRPA	Human	benzo[a]pyrene	decreases expression	ISO	RGD:10243	6480464	Benzo(a)pyrene results in decreased expression of SIRPA mRNA	CTD	PMID:19770486\|PMID:21569818
SIRPA	Human	benzo[a]pyrene	increases methylation	EXP		6480464	Benzo(a)pyrene results in increased methylation of SIRPA 3' UTR	CTD	PMID:27901495
SIRPA	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of SIRPA promoter	CTD	PMID:27901495
SIRPA	Human	benzo[a]pyrene	increases expression	ISO	RGD:10243	6480464	Benzo(a)pyrene results in increased expression of SIRPA mRNA	CTD	PMID:22228805
SIRPA	Human	beta-lapachone	increases expression	EXP		6480464	beta-lapachone results in increased expression of SIRPA mRNA	CTD	PMID:38218311
SIRPA	Human	bisphenol A	affects expression	ISO	RGD:3449	6480464	bisphenol A affects the expression of SIRPA mRNA	CTD	PMID:25181051
SIRPA	Human	bisphenol A	increases expression	ISO	RGD:10243	6480464	bisphenol A results in increased expression of SIRPA mRNA	CTD	PMID:33221593
SIRPA	Human	bisphenol A	increases methylation	ISO	RGD:10243	6480464	bisphenol A results in increased methylation of SIRPA promoter	CTD	PMID:27312807
SIRPA	Human	cadmium atom	decreases expression	ISO	RGD:10243	6480464	Cadmium results in decreased expression of SIRPA mRNA	CTD	PMID:23358151
SIRPA	Human	cadmium dichloride	increases expression	ISO	RGD:3449	6480464	Cadmium Chloride results in increased expression of SIRPA mRNA	CTD	PMID:25993096
SIRPA	Human	cadmium dichloride	decreases expression	EXP		6480464	Cadmium Chloride results in decreased expression of SIRPA mRNA	CTD	PMID:38568856
SIRPA	Human	calcitriol	increases expression	EXP		6480464	Calcitriol results in increased expression of SIRPA mRNA	CTD	PMID:16002434
SIRPA	Human	carbon nanotube	increases expression	ISO	RGD:10243	6480464	Nanotubes, Carbon analog results in increased expression of SIRPA mRNA	CTD	PMID:25554681
SIRPA	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to SIRPA gene]	CTD	PMID:28238834
SIRPA	Human	choline	multiple interactions	ISO	RGD:10243	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ...	CTD	PMID:20938992
SIRPA	Human	copper(II) sulfate	decreases expression	EXP		6480464	Copper Sulfate results in decreased expression of SIRPA mRNA	CTD	PMID:19549813
SIRPA	Human	cycloheximide	multiple interactions	EXP		6480464	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SIRPA mRNA]	CTD	PMID:11007951
SIRPA	Human	cyproconazole	increases expression	ISO	RGD:10243	6480464	cyproconazole results in increased expression of SIRPA mRNA	CTD	PMID:22334560
SIRPA	Human	D-gluconic acid	multiple interactions	ISO	RGD:3449	6480464	[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of SIRPA mRNA	CTD	PMID:16556975
SIRPA	Human	deoxycholic acid	multiple interactions	ISO	RGD:3449	6480464	[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of SIRPA mRNA	CTD	PMID:16556975
SIRPA	Human	diarsenic trioxide	multiple interactions	EXP		6480464	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SIRPA mRNA	CTD	PMID:15894607
SIRPA	Human	diarsenic trioxide	increases expression	EXP		6480464	Arsenic Trioxide results in increased expression of SIRPA mRNA	CTD	PMID:27829220
SIRPA	Human	Dibutyl phosphate	affects expression	EXP		6480464	di-n-butylphosphoric acid affects the expression of SIRPA mRNA	CTD	PMID:37042841
SIRPA	Human	dibutyl phthalate	decreases expression	ISO	RGD:3449	6480464	Dibutyl Phthalate results in decreased expression of SIRPA mRNA	CTD	PMID:21266533
SIRPA	Human	dichlorine	multiple interactions	ISO	RGD:3449	6480464	[Ozone co-treated with Chlorine] results in decreased expression of SIRPA mRNA	CTD	PMID:18636392
SIRPA	Human	elemental selenium	increases expression	EXP		6480464	Selenium results in increased expression of SIRPA mRNA	CTD	PMID:19244175
SIRPA	Human	endosulfan	decreases expression	ISO	RGD:3449	6480464	Endosulfan results in decreased expression of SIRPA mRNA	CTD	PMID:29391264
SIRPA	Human	epoxiconazole	increases expression	ISO	RGD:10243	6480464	epoxiconazole results in increased expression of SIRPA mRNA	CTD	PMID:22334560
SIRPA	Human	ethanol	affects splicing	ISO	RGD:10243	6480464	Ethanol affects the splicing of SIRPA mRNA	CTD	PMID:30319688
SIRPA	Human	fipronil	increases expression	ISO	RGD:3449	6480464	fipronil results in increased expression of SIRPA mRNA	CTD	PMID:34044035
SIRPA	Human	folic acid	multiple interactions	ISO	RGD:10243	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ...	CTD	PMID:20938992
SIRPA	Human	fonofos	increases methylation	EXP		6480464	Fonofos results in increased methylation of SIRPA promoter	CTD	PMID:22847954
SIRPA	Human	gentamycin	decreases expression	ISO	RGD:3449	6480464	Gentamicins results in decreased expression of SIRPA mRNA	CTD	PMID:33387578
SIRPA	Human	glafenine	increases expression	ISO	RGD:3449	6480464	Glafenine results in increased expression of SIRPA mRNA	CTD	PMID:24136188
SIRPA	Human	isotretinoin	increases expression	EXP		6480464	Isotretinoin results in increased expression of SIRPA mRNA	CTD	PMID:20436886
SIRPA	Human	L-methionine	multiple interactions	ISO	RGD:10243	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ...	CTD	PMID:20938992
SIRPA	Human	leflunomide	decreases expression	EXP		6480464	leflunomide results in decreased expression of SIRPA mRNA	CTD	PMID:28988120
SIRPA	Human	lipopolysaccharide	multiple interactions	EXP		6480464	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SIRPA protein inhibits the reaction [Lipopolysaccharides results in increased secretion of more ...	CTD	PMID:12805067
SIRPA	Human	LY294002	multiple interactions	EXP		6480464	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SIRPA protein inhibits the reaction [Lipopolysaccharides results in increased secretion of more ...	CTD	PMID:12805067
SIRPA	Human	menadione	affects expression	EXP		6480464	Vitamin K 3 affects the expression of SIRPA mRNA	CTD	PMID:20044591
SIRPA	Human	methotrexate	increases expression	EXP		6480464	Methotrexate results in increased expression of SIRPA mRNA	CTD	PMID:24449571
SIRPA	Human	methoxychlor	affects expression	ISO	RGD:10243	6480464	Methoxychlor affects the expression of SIRPA mRNA	CTD	PMID:20829426
SIRPA	Human	methoxychlor	affects methylation	ISO	RGD:3449	6480464	Methoxychlor affects the methylation of SIRPA gene	CTD	PMID:35440735
SIRPA	Human	Muraglitazar	decreases expression	ISO	RGD:3449	6480464	muraglitazar results in decreased expression of SIRPA mRNA	CTD	PMID:21515302
SIRPA	Human	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:10243	6480464	[CD47 protein binds to SIRPA protein] inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of more ...	CTD	PMID:28268219
SIRPA	Human	N-nitrosomorpholine	increases expression	ISO	RGD:3449	6480464	N-nitrosomorpholine results in increased expression of SIRPA mRNA	CTD	PMID:19716841
SIRPA	Human	nickel atom	increases expression	EXP		6480464	Nickel results in increased expression of SIRPA mRNA	CTD	PMID:25583101
SIRPA	Human	nickel sulfate	decreases expression	EXP		6480464	nickel sulfate results in decreased expression of SIRPA mRNA	CTD	PMID:22714537
SIRPA	Human	nitrofen	decreases expression	ISO	RGD:3449	6480464	nitrofen results in decreased expression of SIRPA mRNA	CTD	PMID:26720608
SIRPA	Human	NSC 23766	multiple interactions	ISO	RGD:10243	6480464	NSC 23766 inhibits the reaction [[CD47 protein binds to SIRPA protein] inhibits the reaction [1-Methyl-4-phenylpyridinium more ...	CTD	PMID:28268219
SIRPA	Human	ozone	multiple interactions	ISO	RGD:3449	6480464	[Ozone co-treated with Chlorine] results in decreased expression of SIRPA mRNA	CTD	PMID:18636392
SIRPA	Human	paracetamol	decreases expression	EXP		6480464	Acetaminophen results in decreased expression of SIRPA mRNA	CTD	PMID:21420995
SIRPA	Human	paracetamol	decreases expression	ISO	RGD:3449	6480464	Acetaminophen results in decreased expression of SIRPA mRNA	CTD	PMID:32479839\|PMID:33387578
SIRPA	Human	paraquat	increases expression	ISO	RGD:3449	6480464	Paraquat results in increased expression of SIRPA mRNA	CTD	PMID:17077588\|PMID:18198484
SIRPA	Human	parathion	increases methylation	EXP		6480464	Parathion results in increased methylation of SIRPA promoter	CTD	PMID:22847954
SIRPA	Human	perfluorohexanesulfonic acid	increases expression	ISO	RGD:10243	6480464	perfluorohexanesulfonic acid results in increased expression of SIRPA mRNA	CTD	PMID:37995155
SIRPA	Human	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:10243	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SIRPA mRNA	CTD	PMID:36331819
SIRPA	Human	pirinixic acid	increases expression	ISO	RGD:10243	6480464	pirinixic acid results in increased expression of SIRPA mRNA	CTD	PMID:23811191
SIRPA	Human	potassium chromate	decreases expression	EXP		6480464	potassium chromate(VI) results in decreased expression of SIRPA mRNA	CTD	PMID:22714537
SIRPA	Human	progesterone	multiple interactions	EXP		6480464	[Estradiol co-treated with Progesterone] results in decreased expression of SIRPA mRNA	CTD	PMID:20660070
SIRPA	Human	propiconazole	increases expression	ISO	RGD:10243	6480464	propiconazole results in increased expression of SIRPA mRNA	CTD	PMID:22334560
SIRPA	Human	selenium atom	increases expression	EXP		6480464	Selenium results in increased expression of SIRPA mRNA	CTD	PMID:19244175
SIRPA	Human	silicon dioxide	increases expression	ISO	RGD:3449	6480464	Silicon Dioxide results in increased expression of SIRPA mRNA	CTD	PMID:32721576
SIRPA	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of SIRPA mRNA	CTD	PMID:22714537
SIRPA	Human	sodium arsenite	decreases expression	ISO	RGD:10243	6480464	sodium arsenite results in decreased expression of SIRPA mRNA	CTD	PMID:37682722
SIRPA	Human	sodium fluoride	increases expression	ISO	RGD:10243	6480464	Sodium Fluoride results in increased expression of SIRPA mRNA	CTD	PMID:27862939
SIRPA	Human	terbufos	increases methylation	EXP		6480464	terbufos results in increased methylation of SIRPA promoter	CTD	PMID:22847954
SIRPA	Human	Tesaglitazar	decreases expression	ISO	RGD:3449	6480464	tesaglitazar results in decreased expression of SIRPA mRNA	CTD	PMID:21515302
SIRPA	Human	tetrachloroethene	increases expression	ISO	RGD:10243	6480464	Tetrachloroethylene results in increased expression of SIRPA mRNA	CTD	PMID:28973375
SIRPA	Human	tetrachloromethane	affects expression	ISO	RGD:10243	6480464	Carbon Tetrachloride affects the expression of SIRPA mRNA	CTD	PMID:17484886
SIRPA	Human	tetrachloromethane	increases expression	ISO	RGD:10243	6480464	Carbon Tetrachloride results in increased expression of SIRPA mRNA	CTD	PMID:29987408
SIRPA	Human	thimerosal	decreases expression	EXP		6480464	Thimerosal results in decreased expression of SIRPA mRNA	CTD	PMID:27188386
SIRPA	Human	thioacetamide	increases expression	ISO	RGD:3449	6480464	Thioacetamide results in increased expression of SIRPA mRNA	CTD	PMID:23411599\|PMID:34492290
SIRPA	Human	titanium dioxide	increases expression	ISO	RGD:10243	6480464	titanium dioxide results in increased expression of SIRPA mRNA	CTD	PMID:23557971
SIRPA	Human	titanium dioxide	increases methylation	ISO	RGD:10243	6480464	titanium dioxide results in increased methylation of SIRPA gene	CTD	PMID:35295148
SIRPA	Human	titanium dioxide	decreases expression	ISO	RGD:10243	6480464	titanium dioxide results in decreased expression of SIRPA mRNA	CTD	PMID:29264374
SIRPA	Human	trichostatin A	increases expression	EXP		6480464	trichostatin A results in increased expression of SIRPA mRNA	CTD	PMID:24935251
SIRPA	Human	trichostatin A	affects expression	EXP		6480464	trichostatin A affects the expression of SIRPA mRNA	CTD	PMID:28542535
SIRPA	Human	triclosan	decreases expression	EXP		6480464	Triclosan results in decreased expression of SIRPA mRNA	CTD	PMID:30510588
SIRPA	Human	triphenyl phosphate	affects expression	EXP		6480464	triphenyl phosphate affects the expression of SIRPA mRNA	CTD	PMID:37042841
SIRPA	Human	triptonide	increases expression	ISO	RGD:10243	6480464	triptonide results in increased expression of SIRPA mRNA	CTD	PMID:33045310
SIRPA	Human	tris(2-butoxyethyl) phosphate	affects expression	EXP		6480464	tris(2-butoxyethyl) phosphate affects the expression of SIRPA mRNA	CTD	PMID:29024780
SIRPA	Human	troglitazone	decreases expression	ISO	RGD:3449	6480464	troglitazone results in decreased expression of SIRPA mRNA	CTD	PMID:21515302
SIRPA	Human	tungsten	decreases expression	ISO	RGD:10243	6480464	Tungsten results in decreased expression of SIRPA mRNA	CTD	PMID:30912803
SIRPA	Human	valproic acid	increases methylation	EXP		6480464	Valproic Acid results in increased methylation of SIRPA gene	CTD	PMID:29154799
SIRPA	Human	vorinostat	decreases expression	EXP		6480464	vorinostat results in decreased expression of SIRPA mRNA	CTD	PMID:27188386
SIRPA	Human	wortmannin	multiple interactions	EXP		6480464	wortmannin inhibits the reaction [SIRPA protein inhibits the reaction [Lipopolysaccharides results in increased secretion of more ...	CTD	PMID:12805067

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SIRPA	Human	actin filament organization	acts_upstream_of_or_within	ISO	MGI:2388979	9068941	PMID:11118207	MGI	PMID:11118207
SIRPA	Human	cell adhesion	involved_in	TAS		150520179	PMID:9070220	PINC	PMID:9070220
SIRPA	Human	cell migration		ISO	RGD:3449	9068941		RGD	PMID:12023387\|REF_RGD_ID:625650
SIRPA	Human	cell migration	involved_in	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	cell motility	acts_upstream_of_or_within	ISO	MGI:2388979	9068941	PMID:11118207	MGI	PMID:11118207
SIRPA	Human	cell-cell adhesion	involved_in	IEA	GO:0098632	150520179		GOC	GO_REF:0000108
SIRPA	Human	cell-matrix adhesion	acts_upstream_of_or_within	ISO	MGI:2388979	9068941	PMID:11118207	MGI	PMID:11118207
SIRPA	Human	cellular response to hydrogen peroxide	involved_in	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	cellular response to interleukin-1	involved_in	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	cellular response to interleukin-12	involved_in	IMP		150520179	PMID:11509594	ARUK-UCL	PMID:11509594
SIRPA	Human	cellular response to type II interferon	involved_in	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	cytoskeleton organization	acts_upstream_of_or_within	ISO	MGI:2388979	9068941	PMID:11118207	MGI	PMID:11118207
SIRPA	Human	granulocyte migration	involved_in	ISO	UniProtKB:Q62386	9068941	PMID:24026300	ARUK-UCL	PMID:24026300
SIRPA	Human	hematopoietic progenitor cell differentiation	acts_upstream_of_or_within	ISO	RGD:10243	9068941	PMID:24029230	MGI	PMID:24029230
SIRPA	Human	heterotypic cell-cell adhesion	involved_in	IEA	GO:0086080	150520179		GOC	GO_REF:0000108
SIRPA	Human	monocyte extravasation	involved_in	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of canonical NF-kappaB signal transduction	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of chemokine (C-C motif) ligand 5 production	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of cytokine production involved in inflammatory response	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of ERK1 and ERK2 cascade	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of inflammatory response	involved_in	IMP		150520179	PMID:24026300	ARUK-UCL	PMID:24026300
SIRPA	Human	negative regulation of interferon-beta production	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of interleukin-6 production	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of JNK cascade	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of lipopolysaccharide-mediated signaling pathway	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of macrophage inflammatory protein 1 alpha production	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of nitric oxide biosynthetic process	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of phagocytosis	involved_in	ISS	UniProtKB:P97710\|UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	negative regulation of tumor necrosis factor production	involved_in	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	phagocytosis, engulfment	acts_upstream_of_or_within	ISO	RGD:10243	9068941	PMID:14634079	MGI	PMID:14634079
SIRPA	Human	phagocytosis, recognition	acts_upstream_of_or_within	ISO	RGD:10243	9068941	PMID:14634079	MGI	PMID:14634079
SIRPA	Human	positive regulation of phagocytosis	involved_in	IBA	MGI:108563\|PANTHER:PTN000463164	150520179		GO_Central	GO_REF:0000033
SIRPA	Human	positive regulation of phagocytosis	acts_upstream_of_or_within	ISO	RGD:10243	9068941	PMID:14634079	MGI	PMID:14634079
SIRPA	Human	positive regulation of reactive oxygen species metabolic process	involved_in	IDA		150520179	PMID:24511121	UniProt	PMID:24511121
SIRPA	Human	positive regulation of T cell activation	involved_in	IBA	PANTHER:PTN000463164\|UniProtKB:Q9P1W8	150520179		GO_Central	GO_REF:0000033
SIRPA	Human	regulation of gene expression	involved_in	IMP		150520179	PMID:11509594	ARUK-UCL	PMID:11509594
SIRPA	Human	regulation of interleukin-1 beta production	involved_in	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	regulation of interleukin-6 production	involved_in	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	regulation of nitric oxide biosynthetic process	involved_in	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	regulation of tumor necrosis factor production	involved_in	IGI	UniProtKB:Q08722	150520179	PMID:11509594	ARUK-UCL	PMID:11509594
SIRPA	Human	regulation of tumor necrosis factor production	involved_in	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	regulation of type II interferon production	involved_in	IMP		150520179	PMID:11509594	ARUK-UCL	PMID:11509594

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SIRPA	Human	cell surface	located_in	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	cell surface	located_in	IDA		150520179	PMID:11509594	ARUK-UCL	PMID:11509594
SIRPA	Human	cell surface	located_in	TAS		150520179	PMID:25795378	ARUK-UCL	PMID:25795378
SIRPA	Human	extracellular exosome	located_in	HDA		150520179	PMID:19056867	UniProt	PMID:19056867
SIRPA	Human	ficolin-1-rich granule membrane	located_in	TAS		150520179		Reactome	Reactome:R-HSA-6800426
SIRPA	Human	membrane	located_in	IEA	UniProtKB-SubCell:SL-0162	150520179		UniProt	GO_REF:0000044
SIRPA	Human	membrane	located_in	TAS		150520179	PMID:9062191	PINC	PMID:9062191
SIRPA	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
SIRPA	Human	plasma membrane	located_in	IDA		150520179	PMID:24026300	ARUK-UCL	PMID:24026300
SIRPA	Human	plasma membrane	is_active_in	IBA	MGI:108563\|MGI:2444824\|PANTHER:PTN001072596\|UniProtKB:P78324	150520179		GO_Central	GO_REF:0000033
SIRPA	Human	plasma membrane	located_in	TAS		150520179	PMID:9070220	PINC	PMID:9070220\|Reactome:R-HSA-202703\|Reactome:R-HSA-391151\|Reactome:R-HSA-391152\|Reactome:R-HSA-391153\|Reactome:R-HSA-391155\|Reactome:R-HSA-391157\|Reactome:R-HSA-391158\|Reactome:R-HSA-6798747\|Reactome:R-HSA-6800426
SIRPA	Human	tertiary granule membrane	located_in	TAS		150520179		Reactome	Reactome:R-HSA-6798747

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SIRPA	Human	cell-cell adhesion mediator activity	enables	IPI	UniProtKB:Q08722	150520179	PMID:11509594	ARUK-UCL	PMID:11509594
SIRPA	Human	GTPase regulator activity	enables	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	protein antigen binding	enables	IPI	UniProtKB:Q08722	150520179	PMID:24026300	ARUK-UCL	PMID:24026300
SIRPA	Human	protein binding	enables	IPI	UniProtKB:Q08722	150520179	PMID:17070842, PMID:33961781	IntAct	PMID:17070842\|PMID:33961781
SIRPA	Human	protein binding	enables	IPI	UniProtKB:P07996	150520179	PMID:24511121	UniProt	PMID:24511121
SIRPA	Human	protein binding involved in heterotypic cell-cell adhesion	enables	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	protein phosphatase binding	enables	ISS	UniProtKB:P97710\|UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	protein phosphatase inhibitor activity	enables	ISS	UniProtKB:P97797	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	protein phosphorylated amino acid binding	enables	ISO	PR:Q8K558	9068941	PMID:12393607	MGI	PMID:12393607
SIRPA	Human	protein tyrosine kinase binding	enables	ISS	UniProtKB:P97710	150520179		ARUK-UCL	GO_REF:0000024
SIRPA	Human	SH3 domain binding	enables	IEA	UniProtKB-KW:KW-0729	150520179		UniProt	GO_REF:0000043

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:8525433	PMID:8810330	PMID:8943344	PMID:9062191	PMID:9070220	PMID:9271230	PMID:9485180	PMID:9632768	PMID:9712903	PMID:9872987	PMID:10098842	PMID:10469599
PMID:10572074	PMID:10585853	PMID:10660565	PMID:10660620	PMID:10842184	PMID:10962556	PMID:11509594	PMID:11780052	PMID:11792697	PMID:11907074	PMID:12477932	PMID:12483539
PMID:12805067	PMID:14662855	PMID:14729615	PMID:15359629	PMID:15374953	PMID:15489334	PMID:15842360	PMID:15888547	PMID:16189514	PMID:16291597	PMID:16335952	PMID:16339511
PMID:16344560	PMID:16691243	PMID:16697668	PMID:16825188	PMID:17070842	PMID:17098740	PMID:17142753	PMID:17178844	PMID:17360380	PMID:17500595	PMID:17632076	PMID:17954568
PMID:17999719	PMID:18051954	PMID:18647419	PMID:18820737	PMID:18855618	PMID:18954403	PMID:19056867	PMID:19165527	PMID:19299420	PMID:19628875	PMID:19748659	PMID:19820697
PMID:19874234	PMID:20207740	PMID:20299253	PMID:20473329	PMID:20643654	PMID:20705613	PMID:20826546	PMID:20826801	PMID:21169408	PMID:21223598	PMID:21225905	PMID:21369691
PMID:21706016	PMID:21788504	PMID:21788509	PMID:21799000	PMID:21873635	PMID:22139419	PMID:22409853	PMID:22451913	PMID:22490440	PMID:22511785	PMID:22738830	PMID:22747997
PMID:22815949	PMID:23271705	PMID:23314616	PMID:23320069	PMID:23504854	PMID:23669395	PMID:24026300	PMID:24101669	PMID:24124411	PMID:24143245	PMID:24162948	PMID:24511121
PMID:24516072	PMID:24550402	PMID:24968096	PMID:25416956	PMID:25468996	PMID:25795378	PMID:25837251	PMID:26085683	PMID:26116271	PMID:26186194	PMID:26492885	PMID:26534964
PMID:26573233	PMID:27728760	PMID:27793032	PMID:27856600	PMID:27900675	PMID:28514442	PMID:28669759	PMID:29084248	PMID:29158380	PMID:29180619	PMID:30194290	PMID:30639242
PMID:30833751	PMID:30863997	PMID:30888336	PMID:30910815	PMID:31089204	PMID:31507080	PMID:31611550	PMID:32196807	PMID:32240171	PMID:32296183	PMID:32393512	PMID:32433947
PMID:33799989	PMID:33961781	PMID:34009732	PMID:34079125	PMID:34180101	PMID:34349018	PMID:34512146	PMID:34667145	PMID:34917090	PMID:34940829	PMID:35337019	PMID:35737088
PMID:35795660	PMID:36202053	PMID:36215168	PMID:36641515	PMID:36791324	PMID:37660478	PMID:37844448	PMID:38117590	PMID:38245585	PMID:38279488	PMID:38334954	PMID:38758648
PMID:39258954

SIRPA
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	20	1,894,167 - 1,940,592 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	20	1,894,167 - 1,940,592 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	20	1,874,813 - 1,921,238 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	20	1,822,813 - 1,868,540 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	20	1,823,424 - 1,868,535	NCBI
Celera	20	1,938,791 - 1,984,521 (+)	NCBI		Celera
Cytogenetic Map	20	p13	NCBI
HuRef	20	1,824,406 - 1,870,408 (+)	NCBI		HuRef
CHM1_1	20	1,875,015 - 1,920,758 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	20	1,924,358 - 1,970,769 (+)	NCBI		T2T-CHM13v2.0

Sirpa
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	2	129,432,962 - 129,474,148 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	2	129,434,755 - 129,474,148 (+)	Ensembl		GRCm39 Ensembl
GRCm38	2	129,591,042 - 129,632,228 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	2	129,592,835 - 129,632,228 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	2	129,418,575 - 129,457,964 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	2	129,284,759 - 129,322,373 (+)	NCBI		MGSCv36	mm8
Celera	2	130,820,643 - 130,860,425 (+)	NCBI		Celera
Cytogenetic Map	2	F1	NCBI
cM Map	2	63.19	NCBI

Sirpa
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	3	137,272,932 - 137,311,279 (+)	NCBI		GRCr8
mRatBN7.2	3	116,819,730 - 116,858,099 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	3	116,819,726 - 116,858,098 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	3	120,717,512 - 120,755,285 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	3	129,313,130 - 129,350,902 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	3	126,973,615 - 127,011,386 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	3	122,113,735 - 122,152,478 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	3	122,114,108 - 122,152,477 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	3	127,864,145 - 127,902,598 (-)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	3	117,210,116 - 117,247,840 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	3	117,115,688 - 117,153,412 (+)	NCBI
Celera	3	115,635,887 - 115,673,609 (+)	NCBI		Celera
Cytogenetic Map	3	q36	NCBI

Sirpa
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0	NW_004955415	13,030,752 - 13,072,735 (+)	NCBI	ChiLan1.0	ChiLan1.0

SIRPA
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	21	2,887,607 - 2,933,424 (+)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	20	2,884,271 - 2,930,254 (+)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	20	2,006,994 - 2,052,894 (+)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	20	1,773,271 - 1,818,106 (+)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	20	1,773,271 - 1,818,106 (+)	Ensembl	panpan1.1		panPan2

SIRPA
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	24	19,094,930 - 19,136,655 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
Dog10K_Boxer_Tasha	24	18,923,276 - 18,964,758 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	24	19,551,905 - 19,593,551 (-)	NCBI		ROS_Cfam_1.0
UMICH_Zoey_3.1	24	19,108,428 - 19,149,479 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	24	19,218,798 - 19,260,377 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	24	19,547,368 - 19,588,981 (-)	NCBI		UU_Cfam_GSD_1.0

Sirpa
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024408640	168,176,954 - 168,219,753 (-)	NCBI		HiC_Itri_2
SpeTri2.0	NW_004936485	16,608,317 - 16,654,552 (-)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

SIRPA
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1	17	33,566,270 - 33,611,375 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	17	37,961,460 - 37,968,581 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

LOC103215732
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	2	54,590,151 - 54,636,381 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
Vero_WHO_p1.0	NW_023666087	1,006,396 - 1,052,664 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Sirpa
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla 1.0	NW_004624741	3,157,734 - 3,202,018 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in SIRPA
71 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 20p13-11.21(chr20:89939-25697564)x3	copy number gain	See cases [RCV000051227]	Chr20:89939..25697564 [GRCh38] Chr20:70580..25678200 [GRCh37] Chr20:18580..25626200 [NCBI36] Chr20:20p13-11.21	pathogenic
GRCh38/hg38 20p13-11.23(chr20:89939-19146279)x3	copy number gain	See cases [RCV000051041]	Chr20:89939..19146279 [GRCh38] Chr20:70580..19126923 [GRCh37] Chr20:18580..19074923 [NCBI36] Chr20:20p13-11.23	pathogenic
GRCh38/hg38 20p13(chr20:89939-1939218)x1	copy number loss	See cases [RCV000052735]	Chr20:89939..1939218 [GRCh38] Chr20:70580..1919864 [GRCh37] Chr20:18580..1867864 [NCBI36] Chr20:20p13	pathogenic
GRCh38/hg38 20p13(chr20:121781-2290194)x1	copy number loss	See cases [RCV000052738]	Chr20:121781..2290194 [GRCh38] Chr20:102422..2270840 [GRCh37] Chr20:50422..2218840 [NCBI36] Chr20:20p13	pathogenic
GRCh38/hg38 20p13-11.23(chr20:89939-19071495)x3	copy number gain	See cases [RCV000052995]	Chr20:89939..19071495 [GRCh38] Chr20:70580..19052139 [GRCh37] Chr20:18580..19000139 [NCBI36] Chr20:20p13-11.23	pathogenic
GRCh38/hg38 20p13-11.22(chr20:89939-21787252)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052996]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052996]\|See cases [RCV000052996]	Chr20:89939..21787252 [GRCh38] Chr20:70580..21767890 [GRCh37] Chr20:18580..21715890 [NCBI36] Chr20:20p13-11.22	pathogenic
GRCh38/hg38 20p13-12.1(chr20:89939-14818511)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052997]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052997]\|See cases [RCV000052997]	Chr20:89939..14818511 [GRCh38] Chr20:70580..14799157 [GRCh37] Chr20:18580..14747157 [NCBI36] Chr20:20p13-12.1	pathogenic
GRCh37/hg19 20p13(chr20:71023-2129746)x1	copy number loss	See cases [RCV000184090]	Chr20:71023..2129746 [GRCh37] Chr20:20p13	pathogenic
GRCh38/hg38 20p13-q11.1(chr20:80106-30227427)x3	copy number gain	See cases [RCV000133996]	Chr20:80106..30227427 [GRCh38] Chr20:60747..29462103 [GRCh37] Chr20:8747..28075764 [NCBI36] Chr20:20p13-q11.1	pathogenic
GRCh38/hg38 20p13-q13.33(chr20:99557-64277321)x3	copy number gain	See cases [RCV000135859]	Chr20:99557..64277321 [GRCh38] Chr20:80198..62908674 [GRCh37] Chr20:28198..62379118 [NCBI36] Chr20:20p13-q13.33	pathogenic
GRCh38/hg38 20p13-12.1(chr20:80106-13029401)x3	copy number gain	See cases [RCV000138677]	Chr20:80106..13029401 [GRCh38] Chr20:60747..13010049 [GRCh37] Chr20:8747..12958049 [NCBI36] Chr20:20p13-12.1	pathogenic
GRCh38/hg38 20p13-12.3(chr20:80093-6386012)x3	copy number gain	See cases [RCV000139597]	Chr20:80093..6386012 [GRCh38] Chr20:60734..6366659 [GRCh37] Chr20:8734..6314659 [NCBI36] Chr20:20p13-12.3	pathogenic
GRCh38/hg38 20p13-12.3(chr20:84402-6159078)x3	copy number gain	See cases [RCV000141348]	Chr20:84402..6159078 [GRCh38] Chr20:65043..6139725 [GRCh37] Chr20:13043..6087725 [NCBI36] Chr20:20p13-12.3	pathogenic
GRCh38/hg38 20p13-11.1(chr20:80927-26324843)x3	copy number gain	See cases [RCV000142017]	Chr20:80927..26324843 [GRCh38] Chr20:61568..26305479 [GRCh37] Chr20:9568..26253479 [NCBI36] Chr20:20p13-11.1	pathogenic
GRCh38/hg38 20p13-12.3(chr20:80927-5447679)x3	copy number gain	See cases [RCV000142285]	Chr20:80927..5447679 [GRCh38] Chr20:61568..5428325 [GRCh37] Chr20:9568..5376325 [NCBI36] Chr20:20p13-12.3	uncertain significance
GRCh38/hg38 20p13-12.3(chr20:1269303-8626911)x3	copy number gain	See cases [RCV000142917]	Chr20:1269303..8626911 [GRCh38] Chr20:1249947..8607558 [GRCh37] Chr20:1197947..8555558 [NCBI36] Chr20:20p13-12.3	pathogenic
GRCh38/hg38 20p13-11.23(chr20:80928-18688031)x3	copy number gain	See cases [RCV000143426]	Chr20:80928..18688031 [GRCh38] Chr20:61569..18668675 [GRCh37] Chr20:9569..18616675 [NCBI36] Chr20:20p13-11.23	pathogenic
GRCh37/hg19 20p13-12.3(chr20:121521-5564937)x3	copy number gain	See cases [RCV000239772]	Chr20:121521..5564937 [GRCh37] Chr20:20p13-12.3	pathogenic
GRCh37/hg19 20p13-11.1(chr20:80198-26075841)x3	copy number gain	See cases [RCV000239954]	Chr20:80198..26075841 [GRCh37] Chr20:20p13-11.1	pathogenic
GRCh37/hg19 20p13(chr20:61568-4914872)x3	copy number gain	See cases [RCV000446883]	Chr20:61568..4914872 [GRCh37] Chr20:20p13	pathogenic
GRCh37/hg19 20p13(chr20:121521-2073612)x1	copy number loss	See cases [RCV000446640]	Chr20:121521..2073612 [GRCh37] Chr20:20p13	pathogenic
GRCh37/hg19 20p13(chr20:61568-4904599)x3	copy number gain	See cases [RCV000448397]	Chr20:61568..4904599 [GRCh37] Chr20:20p13	pathogenic
GRCh37/hg19 20p13-q11.21(chr20:80198-26208081)x3	copy number gain	not provided [RCV000487461]	Chr20:80198..26208081 [GRCh37] Chr20:20p13-q11.21	pathogenic
GRCh37/hg19 20p13-12.3(chr20:213423-5483406)x3	copy number gain	See cases [RCV000510531]	Chr20:213423..5483406 [GRCh37] Chr20:20p13-12.3	uncertain significance
GRCh37/hg19 20p13(chr20:61568-2824960)x3	copy number gain	See cases [RCV000511991]	Chr20:61568..2824960 [GRCh37] Chr20:20p13	uncertain significance
GRCh37/hg19 20p13-q13.33(chr20:61569-62915555)x3	copy number gain	See cases [RCV000510832]	Chr20:61569..62915555 [GRCh37] Chr20:20p13-q13.33	pathogenic
NM_001040023.2(SIRPA):c.658G>A (p.Glu220Lys)	single nucleotide variant	not specified [RCV004290309]	Chr20:1921616 [GRCh38] Chr20:1902262 [GRCh37] Chr20:20p13	uncertain significance
GRCh37/hg19 20p13-q13.33(chr20:61569-62915555)	copy number gain	See cases [RCV000512450]	Chr20:61569..62915555 [GRCh37] Chr20:20p13-q13.33	pathogenic
GRCh37/hg19 20p13-12.2(chr20:61568-10486106)x3	copy number gain	See cases [RCV000512556]	Chr20:61568..10486106 [GRCh37] Chr20:20p13-12.2	likely pathogenic
GRCh37/hg19 20p13(chr20:61568-2010334)x1	copy number loss	not provided [RCV000684132]	Chr20:61568..2010334 [GRCh37] Chr20:20p13	likely pathogenic
GRCh37/hg19 20p13-q13.33(chr20:63244-62948788)x3	copy number gain	not provided [RCV000741058]	Chr20:63244..62948788 [GRCh37] Chr20:20p13-q13.33	pathogenic
GRCh37/hg19 20p13-q13.33(chr20:63244-62961294)x3	copy number gain	not provided [RCV000741059]	Chr20:63244..62961294 [GRCh37] Chr20:20p13-q13.33	pathogenic
GRCh37/hg19 20p13(chr20:1895079-1895490)x0	copy number loss	not provided [RCV000741069]	Chr20:1895079..1895490 [GRCh37] Chr20:20p13	benign
GRCh37/hg19 20p13-q13.33(chr20:63244-62912463)x3	copy number gain	not provided [RCV000741057]	Chr20:63244..62912463 [GRCh37] Chr20:20p13-q13.33	pathogenic
NM_001040023.2(SIRPA):c.1389G>A (p.Ala463=)	single nucleotide variant	not provided [RCV000923960]	Chr20:1937442 [GRCh38] Chr20:1918088 [GRCh37] Chr20:20p13	likely benign
NM_001040023.2(SIRPA):c.637G>A (p.Ala213Thr)	single nucleotide variant	not provided [RCV000882878]	Chr20:1921595 [GRCh38] Chr20:1902241 [GRCh37] Chr20:20p13	benign
NM_001040023.2(SIRPA):c.754+6A>G	single nucleotide variant	not provided [RCV000950287]	Chr20:1921718 [GRCh38] Chr20:1902364 [GRCh37] Chr20:20p13	benign
NM_001040023.2(SIRPA):c.1059G>A (p.Pro353=)	single nucleotide variant	not provided [RCV000894471]	Chr20:1922617 [GRCh38] Chr20:1903263 [GRCh37] Chr20:20p13	likely benign
GRCh37/hg19 20p13(chr20:61568-2269777)x1	copy number loss	not provided [RCV001007065]	Chr20:61568..2269777 [GRCh37] Chr20:20p13	pathogenic
NM_001040023.2(SIRPA):c.1071C>T (p.Gly357=)	single nucleotide variant	not provided [RCV000893170]	Chr20:1922629 [GRCh38] Chr20:1903275 [GRCh37] Chr20:20p13	benign
GRCh37/hg19 20p13(chr20:1886492-2028451)x3	copy number gain	not provided [RCV000846348]	Chr20:1886492..2028451 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.613G>A (p.Val205Met)	single nucleotide variant	not specified [RCV004319190]	Chr20:1921571 [GRCh38] Chr20:1902217 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1025G>C (p.Ser342Thr)	single nucleotide variant	not provided [RCV000883105]	Chr20:1922583 [GRCh38] Chr20:1903229 [GRCh37] Chr20:20p13	likely benign
NM_001040023.2(SIRPA):c.601G>A (p.Val201Ile)	single nucleotide variant	not provided [RCV000887181]	Chr20:1921559 [GRCh38] Chr20:1902205 [GRCh37] Chr20:20p13	benign
NM_001040023.2(SIRPA):c.1392G>A (p.Ser464=)	single nucleotide variant	not provided [RCV000897226]	Chr20:1937445 [GRCh38] Chr20:1918091 [GRCh37] Chr20:20p13	likely benign
NM_001040023.2(SIRPA):c.1380G>A (p.Pro460=)	single nucleotide variant	not provided [RCV000892755]	Chr20:1937433 [GRCh38] Chr20:1918079 [GRCh37] Chr20:20p13	benign
NM_001040023.2(SIRPA):c.1444C>T (p.Pro482Ser)	single nucleotide variant	not provided [RCV000958240]	Chr20:1937497 [GRCh38] Chr20:1918143 [GRCh37] Chr20:20p13	likely benign
GRCh37/hg19 20p13-11.1(chr20:61568-26305479)x3	copy number gain	not provided [RCV001007068]	Chr20:61568..26305479 [GRCh37] Chr20:20p13-11.1	pathogenic
GRCh37/hg19 20p13(chr20:1886492-2028451)x4	copy number gain	not provided [RCV001258902]	Chr20:1886492..2028451 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1180G>A (p.Val394Ile)	single nucleotide variant	not specified [RCV004125984]	Chr20:1924856 [GRCh38] Chr20:1905502 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.587C>G (p.Thr196Ser)	single nucleotide variant	not specified [RCV004096464]	Chr20:1921545 [GRCh38] Chr20:1902191 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1457C>T (p.Ala486Val)	single nucleotide variant	not specified [RCV004170237]	Chr20:1937510 [GRCh38] Chr20:1918156 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.908C>T (p.Thr303Ile)	single nucleotide variant	not specified [RCV004107691]	Chr20:1922466 [GRCh38] Chr20:1903112 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.842A>G (p.Gln281Arg)	single nucleotide variant	not specified [RCV004241687]	Chr20:1922400 [GRCh38] Chr20:1903046 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.664G>C (p.Val222Leu)	single nucleotide variant	not specified [RCV004172997]	Chr20:1921622 [GRCh38] Chr20:1902268 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1495G>A (p.Val499Ile)	single nucleotide variant	not specified [RCV004143790]	Chr20:1937548 [GRCh38] Chr20:1918194 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.887C>T (p.Thr296Ile)	single nucleotide variant	not specified [RCV004157804]	Chr20:1922445 [GRCh38] Chr20:1903091 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1496T>C (p.Val499Ala)	single nucleotide variant	not specified [RCV004216833]	Chr20:1937549 [GRCh38] Chr20:1918195 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1211C>T (p.Ser404Phe)	single nucleotide variant	not specified [RCV004136129]	Chr20:1927884 [GRCh38] Chr20:1908530 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1396G>A (p.Asp466Asn)	single nucleotide variant	not specified [RCV004125656]	Chr20:1937449 [GRCh38] Chr20:1918095 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.985C>G (p.Leu329Val)	single nucleotide variant	not specified [RCV004118613]	Chr20:1922543 [GRCh38] Chr20:1903189 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1114A>T (p.Ile372Phe)	single nucleotide variant	not specified [RCV004137800]	Chr20:1924790 [GRCh38] Chr20:1905436 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.470C>T (p.Ala157Val)	single nucleotide variant	not specified [RCV004084133]	Chr20:1921428 [GRCh38] Chr20:1902074 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.748A>G (p.Ile250Val)	single nucleotide variant	not specified [RCV004258669]	Chr20:1921706 [GRCh38] Chr20:1902352 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1107A>C (p.Glu369Asp)	single nucleotide variant	not specified [RCV004277781]	Chr20:1924783 [GRCh38] Chr20:1905429 [GRCh37] Chr20:20p13	uncertain significance
GRCh38/hg38 20p13-11.21(chr20:87153-23635465)x3	copy number gain	Renal agenesis [RCV003327640]	Chr20:87153..23635465 [GRCh38] Chr20:20p13-11.21	pathogenic
NM_001040023.2(SIRPA):c.857C>G (p.Thr286Ser)	single nucleotide variant	not specified [RCV004342463]	Chr20:1922415 [GRCh38] Chr20:1903061 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1388C>G (p.Ala463Gly)	single nucleotide variant	not specified [RCV004338035]	Chr20:1937441 [GRCh38] Chr20:1918087 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1424T>G (p.Met475Arg)	single nucleotide variant	not specified [RCV004360708]	Chr20:1937477 [GRCh38] Chr20:1918123 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.799A>G (p.Asn267Asp)	single nucleotide variant	not specified [RCV004356671]	Chr20:1922357 [GRCh38] Chr20:1903003 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.511G>A (p.Glu171Lys)	single nucleotide variant	not specified [RCV004343136]	Chr20:1921469 [GRCh38] Chr20:1902115 [GRCh37] Chr20:20p13	likely benign
NM_001040023.2(SIRPA):c.1363A>G (p.Ser455Gly)	single nucleotide variant	not specified [RCV004353683]	Chr20:1937416 [GRCh38] Chr20:1918062 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.496G>C (p.Val166Leu)	single nucleotide variant	not specified [RCV004363818]	Chr20:1921454 [GRCh38] Chr20:1902100 [GRCh37] Chr20:20p13	uncertain significance
GRCh37/hg19 20p13-12.2(chr20:61569-9542361)x3	copy number gain	not provided [RCV003485207]	Chr20:61569..9542361 [GRCh37] Chr20:20p13-12.2	pathogenic
Single allele	deletion	not provided [RCV003448677]	Chr20:61001..2316914 [GRCh37] Chr20:20p13	pathogenic
GRCh37/hg19 20p13-12.1(chr20:68351-16142323)x3	copy number gain	not provided [RCV003885494]	Chr20:68351..16142323 [GRCh37] Chr20:20p13-12.1	pathogenic
NM_001040023.2(SIRPA):c.353C>T (p.Thr118Ile)	single nucleotide variant	not provided [RCV003886164]	Chr20:1915372 [GRCh38] Chr20:1896018 [GRCh37] Chr20:20p13	likely benign
GRCh37/hg19 20p13-11.21(chr20:68351-23860313)x3	copy number gain	not provided [RCV003885495]	Chr20:68351..23860313 [GRCh37] Chr20:20p13-11.21	pathogenic
NM_001040023.2(SIRPA):c.971G>C (p.Arg324Thr)	single nucleotide variant	not specified [RCV004453885]	Chr20:1922529 [GRCh38] Chr20:1903175 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.934T>A (p.Trp312Arg)	single nucleotide variant	not specified [RCV004453884]	Chr20:1922492 [GRCh38] Chr20:1903138 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.805G>T (p.Val269Leu)	single nucleotide variant	not specified [RCV004453883]	Chr20:1922363 [GRCh38] Chr20:1903009 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1399A>G (p.Thr467Ala)	single nucleotide variant	not specified [RCV004453881]	Chr20:1937452 [GRCh38] Chr20:1918098 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.220C>T (p.Pro74Ser)	single nucleotide variant	not specified [RCV004453882]	Chr20:1915239 [GRCh38] Chr20:1895885 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.664G>A (p.Val222Ile)	single nucleotide variant	not specified [RCV004669917]	Chr20:1921622 [GRCh38] Chr20:1902268 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.656G>A (p.Arg219His)	single nucleotide variant	not specified [RCV004864311]	Chr20:1921614 [GRCh38] Chr20:1902260 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.715C>T (p.Pro239Ser)	single nucleotide variant	not specified [RCV004864312]	Chr20:1921673 [GRCh38] Chr20:1902319 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.655C>T (p.Arg219Cys)	single nucleotide variant	not specified [RCV004864313]	Chr20:1921613 [GRCh38] Chr20:1902259 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1081G>A (p.Ala361Thr)	single nucleotide variant	not specified [RCV004864314]	Chr20:1922639 [GRCh38] Chr20:1903285 [GRCh37] Chr20:20p13	likely benign
NM_001040023.2(SIRPA):c.598C>T (p.Pro200Ser)	single nucleotide variant	not specified [RCV004864315]	Chr20:1921556 [GRCh38] Chr20:1902202 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1237C>G (p.Pro413Ala)	single nucleotide variant	not specified [RCV004864316]	Chr20:1934725 [GRCh38] Chr20:1915371 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.341C>G (p.Ala114Gly)	single nucleotide variant	not specified [RCV004864318]	Chr20:1915360 [GRCh38] Chr20:1896006 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.1352C>T (p.Thr451Met)	single nucleotide variant	not specified [RCV004864319]	Chr20:1937405 [GRCh38] Chr20:1918051 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.971G>A (p.Arg324Lys)	single nucleotide variant	not specified [RCV004864320]	Chr20:1922529 [GRCh38] Chr20:1903175 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.752G>A (p.Arg251Gln)	single nucleotide variant	not specified [RCV004864321]	Chr20:1921710 [GRCh38] Chr20:1902356 [GRCh37] Chr20:20p13	uncertain significance
NM_001040023.2(SIRPA):c.487C>G (p.Gln163Glu)	single nucleotide variant	not specified [RCV004348633]	Chr20:1921445 [GRCh38] Chr20:1902091 [GRCh37] Chr20:20p13	likely benign

Confirmed Target Of

miRNA Gene	Mature miRNA	Method Name	Result Type	Data Type	Support Type	PMID
MIR20A	hsa-miR-20a-5p	Mirtarbase	external_info	Luciferase reporter assay	Functional MTI	23562609
MIR17	hsa-miR-17-5p	Mirtarbase	external_info	Luciferase reporter assay	Functional MTI	23562609
MIR106A	hsa-miR-106a-5p	Mirtarbase	external_info	Luciferase reporter assay	Functional MTI	23562609

Predicted Target Of

	Summary Value
Count of predictions:	3468
Count of miRNA genes:	705
Interacting mature miRNAs:	782
Transcripts:	ENST00000356025, ENST00000358771, ENST00000400068
Prediction methods:	Miranda, Rnahybrid
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597322715	GWAS1418789_H	level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum QTL GWAS1418789 (human)		7e-384	level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum		20	1903644	1903645	Human
597267039	GWAS1363113_H	tyrosine-protein phosphatase non-receptor type 1 measurement QTL GWAS1363113 (human)		3e-287	tyrosine-protein phosphatase non-receptor type 1 measurement		20	1908219	1908220	Human
406892743	GWAS541719_H	basophil percentage of granulocytes QTL GWAS541719 (human)		4e-11	basophil quantity (VT:0002607)		20	1939932	1939933	Human
597072399	GWAS1168473_H	blood protein measurement QTL GWAS1168473 (human)		2e-1072	blood protein amount (VT:0005416)	blood protein measurement (CMO:0000028)	20	1913689	1913690	Human
597300675	GWAS1396749_H	tyrosine-protein phosphatase non-receptor type substrate 1 measurement QTL GWAS1396749 (human)		2e-822	tyrosine-protein phosphatase non-receptor type substrate 1 measurement		20	1915180	1915181	Human
597273155	GWAS1369229_H	tyrosine-protein phosphatase non-receptor type 1 measurement QTL GWAS1369229 (human)		4e-15	tyrosine-protein phosphatase non-receptor type 1 measurement		20	1919180	1919181	Human
597514631	GWAS1610705_H	aging QTL GWAS1610705 (human)		0.0000008	aging		20	1933632	1933633	Human
597273154	GWAS1369228_H	tyrosine-protein phosphatase non-receptor type 1 measurement QTL GWAS1369228 (human)		8e-18	tyrosine-protein phosphatase non-receptor type 1 measurement		20	1898505	1898506	Human
597300676	GWAS1396750_H	tyrosine-protein phosphatase non-receptor type substrate 1 measurement QTL GWAS1396750 (human)		8e-1361	tyrosine-protein phosphatase non-receptor type substrate 1 measurement		20	1915642	1915643	Human
597273158	GWAS1369232_H	tyrosine-protein phosphatase non-receptor type 1 measurement QTL GWAS1369232 (human)		3e-11	tyrosine-protein phosphatase non-receptor type 1 measurement		20	1923869	1923870	Human
597284539	GWAS1380613_H	tyrosine-protein phosphatase non-receptor type substrate 1 measurement QTL GWAS1380613 (human)		3e-106	tyrosine-protein phosphatase non-receptor type substrate 1 measurement		20	1912475	1912476	Human
597284538	GWAS1380612_H	tyrosine-protein phosphatase non-receptor type substrate 1 measurement QTL GWAS1380612 (human)		1e-10	tyrosine-protein phosphatase non-receptor type substrate 1 measurement		20	1896504	1896505	Human
597303481	GWAS1399555_H	level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum QTL GWAS1399555 (human)		2e-263	level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum		20	1913689	1913690	Human
597272945	GWAS1369019_H	tyrosine-protein phosphatase non-receptor type 1 measurement QTL GWAS1369019 (human)		2e-20	tyrosine-protein phosphatase non-receptor type 1 measurement		20	1912924	1912925	Human
597585207	GWAS1642067_H	type 2 diabetes mellitus QTL GWAS1642067 (human)		1e-08	type 2 diabetes mellitus		20	1913101	1913102	Human
597272944	GWAS1369018_H	tyrosine-protein phosphatase non-receptor type 1 measurement QTL GWAS1369018 (human)		1e-29	tyrosine-protein phosphatase non-receptor type 1 measurement		20	1918359	1918361	Human
597046527	GWAS1142601_H	Red cell distribution width QTL GWAS1142601 (human)		5e-12	mitochondrial DNA measurement	red blood cell distribution width- standard deviation (CMO:0003232)	20	1939932	1939933	Human
597152696	GWAS1248770_H	lifestyle measurement, anxiety disorder measurement QTL GWAS1248770 (human)		1e-10	anxiety-related behavior trait (VT:0010716)		20	1896812	1896813	Human
597272939	GWAS1369013_H	tyrosine-protein phosphatase non-receptor type 1 measurement QTL GWAS1369013 (human)		4e-303	tyrosine-protein phosphatase non-receptor type 1 measurement		20	1913960	1913961	Human
597277419	GWAS1373493_H	beverage consumption measurement QTL GWAS1373493 (human)		5e-12	beverage consumption measurement	drink intake measurement (CMO:0000771)	20	1914975	1914976	Human
597272941	GWAS1369015_H	tyrosine-protein phosphatase non-receptor type 1 measurement QTL GWAS1369015 (human)		5e-38	tyrosine-protein phosphatase non-receptor type 1 measurement		20	1898803	1898804	Human
597272940	GWAS1369014_H	tyrosine-protein phosphatase non-receptor type 1 measurement QTL GWAS1369014 (human)		2e-62	tyrosine-protein phosphatase non-receptor type 1 measurement		20	1904497	1904498	Human
597106401	GWAS1202475_H	reticulocyte count QTL GWAS1202475 (human)		4e-13	reticulocyte quantity (VT:0003135)	total reticulocyte count (CMO:0003020)	20	1939959	1939960	Human
597272942	GWAS1369016_H	tyrosine-protein phosphatase non-receptor type 1 measurement QTL GWAS1369016 (human)		1e-37	tyrosine-protein phosphatase non-receptor type 1 measurement		20	1916442	1916443	Human
597428902	GWAS1524976_H	protein measurement QTL GWAS1524976 (human)		1e-310	protein measurement		20	1913669	1913670	Human
597177316	GWAS1273390_H	tyrosine-protein phosphatase non-receptor type substrate 1 measurement QTL GWAS1273390 (human)		1e-5100	tyrosine-protein phosphatase non-receptor type substrate 1 measurement		20	1912475	1912476	Human
406992447	GWAS641423_H	reticulocyte count QTL GWAS641423 (human)		5e-16	reticulocyte quantity (VT:0003135)	total reticulocyte count (CMO:0003020)	20	1939959	1939960	Human

RH68309

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,918,424 - 1,918,551	UniSTS	GRCh37
Build 36	20	1,866,424 - 1,866,551	RGD	NCBI36
Celera	20	1,982,402 - 1,982,529	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,868,286 - 1,868,413	UniSTS

D20S793

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,898,591 - 1,898,692	UniSTS	GRCh37
Build 36	20	1,846,591 - 1,846,692	RGD	NCBI36
Celera	20	1,962,569 - 1,962,670	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,848,463 - 1,848,564	UniSTS
TNG Radiation Hybrid Map	20	1178.0	UniSTS
Stanford-G3 RH Map	20	113.0	UniSTS
NCBI RH Map	20	19.4	UniSTS

PTPNS1_1575

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,919,811 - 1,920,707	UniSTS	GRCh37
Build 36	20	1,867,811 - 1,868,707	RGD	NCBI36
Celera	20	1,983,792 - 1,984,688	RGD
HuRef	20	1,869,679 - 1,870,575	UniSTS

D20S203E

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,920,280 - 1,920,457	UniSTS	GRCh37
Build 36	20	1,868,280 - 1,868,457	RGD	NCBI36
Celera	20	1,984,261 - 1,984,438	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,870,148 - 1,870,325	UniSTS

SHGC-31938

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,918,959 - 1,919,108	UniSTS	GRCh37
Build 36	20	1,866,959 - 1,867,108	RGD	NCBI36
Celera	20	1,982,940 - 1,983,089	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,868,827 - 1,868,976	UniSTS
GeneMap99-GB4 RH Map	20	11.04	UniSTS
GeneMap99-GB4 RH Map	20	13.18	UniSTS
Whitehead-RH Map	20	19.9	UniSTS
NCBI RH Map	20	9.8	UniSTS
GeneMap99-G3 RH Map	20	118.0	UniSTS

G18068

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,898,208 - 1,898,394	UniSTS	GRCh37
Build 36	20	1,846,208 - 1,846,394	RGD	NCBI36
Celera	20	1,962,186 - 1,962,372	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,848,080 - 1,848,266	UniSTS

BCD2069

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,920,330 - 1,920,429	UniSTS	GRCh37
Build 36	20	1,868,330 - 1,868,429	RGD	NCBI36
Celera	20	1,984,311 - 1,984,410	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,870,198 - 1,870,297	UniSTS
GeneMap99-GB4 RH Map	20	11.04	UniSTS

WI-14028

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,903,263 - 1,903,362	UniSTS	GRCh37
Build 36	20	1,851,263 - 1,851,362	RGD	NCBI36
Celera	20	1,967,241 - 1,967,340	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,853,133 - 1,853,232	UniSTS
GeneMap99-GB4 RH Map	20	10.26	UniSTS
GeneMap99-GB4 RH Map	20	11.14	UniSTS
Whitehead-RH Map	20	19.9	UniSTS
NCBI RH Map	20	28.2	UniSTS

STS-M78966

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,919,114 - 1,919,215	UniSTS	GRCh37
Build 36	20	1,867,114 - 1,867,215	RGD	NCBI36
Celera	20	1,983,095 - 1,983,196	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,868,982 - 1,869,083	UniSTS
GeneMap99-GB4 RH Map	20	12.19	UniSTS

D20S1066

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,920,287 - 1,920,519	UniSTS	GRCh37
Build 36	20	1,868,287 - 1,868,519	RGD	NCBI36
Celera	20	1,984,268 - 1,984,500	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,870,155 - 1,870,387	UniSTS
GeneMap99-GB4 RH Map	20	9.78	UniSTS
GeneMap99-GB4 RH Map	20	10.26	UniSTS
Whitehead-RH Map	20	15.1	UniSTS
Whitehead-YAC Contig Map	20		UniSTS

RH11752

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,920,287 - 1,920,428	UniSTS	GRCh37
Build 36	20	1,868,287 - 1,868,428	RGD	NCBI36
Celera	20	1,984,268 - 1,984,409	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,870,155 - 1,870,296	UniSTS
GeneMap99-GB4 RH Map	20	15.0	UniSTS
NCBI RH Map	20	28.8	UniSTS

STS-D29515

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	1,918,748 - 1,918,997	UniSTS	GRCh37
Build 36	20	1,866,748 - 1,866,997	RGD	NCBI36
Celera	20	1,982,729 - 1,982,978	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	1,868,616 - 1,868,865	UniSTS
GeneMap99-GB4 RH Map	20	11.04	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2411	2788	2238	4965	1720	2326	4	623	1883	464	2268	7212	6400	52	3729	1	850	1737	1592	173	1


RefSeq Transcripts	NM_001040022	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001040023	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001330728	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_080792	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_005260670	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_006723545	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011529173	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_024451836	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047439915	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047439916	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047439917	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047439918	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047439919	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047439920	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054323047	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054323048	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054323049	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054323050	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054323051	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054323052	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054323053	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054323054	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AB023430	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK290776	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK298243	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK312521	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL034562	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL117335	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC026692	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC033092	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC038510	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC075849	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471133	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068258	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	D86043	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DA471662	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DN989886	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	U06681	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	U06701	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	Y10375	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	Y11047	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000356025 ⟹ ENSP00000348307

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	20	1,894,783 - 1,939,897 (+)	Ensembl

Ensembl Acc Id:

ENST00000358771 ⟹ ENSP00000351621

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	20	1,895,407 - 1,940,592 (+)	Ensembl

Ensembl Acc Id:

ENST00000400068 ⟹ ENSP00000382941

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	20	1,894,167 - 1,939,894 (+)	Ensembl

Ensembl Acc Id:

ENST00000622179 ⟹ ENSP00000478763

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	20	1,894,508 - 1,940,592 (+)	Ensembl

RefSeq Acc Id:

NM_001040022 ⟹ NP_001035111

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,167 - 1,939,894 (+)	NCBI
GRCh37	20	1,874,763 - 1,920,540 (+)	NCBI
Build 36	20	1,822,813 - 1,868,540 (+)	NCBI Archive
HuRef	20	1,824,406 - 1,870,408 (+)	ENTREZGENE
CHM1_1	20	1,875,015 - 1,920,758 (+)	NCBI
T2T-CHM13v2.0	20	1,924,358 - 1,970,071 (+)	NCBI

Sequence:

show sequence

TCCGGCCCGCACCCACCCCCAAGAGGGGCCTTCAGCTTTGGGGCTCAGAGGCACGACCTCCTGGGGAGGGTTAAAAGGCAGACGCCCCCCCGCCCCCCGCGCCCCCGCGCCCCGACTCCTTCGCCGCC
TCCAGCCTCTCGCCAGTGGGAAGCGGGGAGCAGCCGCGCGGCCGGAGTCCGGAGGCGAGGGGAGGTCGGCCGCAACTTCCCCGGTCCACCTTAAGAGGACGATGTAGCCAGCTCGCAGCGCTGACCTT
AGAAAAACAAGTTTGCGCAAAGTGGAGCGGGGACCCGGCCTCTGGGCAGCCCCGGCGGCGCTTCCAGTGCCTTCCAGCCCTCGCGGGCGGCGCAGCCGCGGCCCATGGAGCCCGCCGGCCCGGCCCCC
GGCCGCCTCGGGCCGCTGCTCTGCCTGCTGCTCGCCGCGTCCTGCGCCTGGTCAGGAGTGGCGGGTGAGGAGGAGCTGCAGGTGATTCAGCCTGACAAGTCCGTGTTGGTTGCAGCTGGAGAGACAGC
CACTCTGCGCTGCACTGCGACCTCTCTGATCCCTGTGGGGCCCATCCAGTGGTTCAGAGGAGCTGGACCAGGCCGGGAATTAATCTACAATCAAAAAGAAGGCCACTTCCCCCGGGTAACAACTGTTT
CAGACCTCACAAAGAGAAACAACATGGACTTTTCCATCCGCATCGGTAACATCACCCCAGCAGATGCCGGCACCTACTACTGTGTGAAGTTCCGGAAAGGGAGCCCCGATGACGTGGAGTTTAAGTCT
GGAGCAGGCACTGAGCTGTCTGTGCGCGCCAAACCCTCTGCCCCCGTGGTATCGGGCCCTGCGGCGAGGGCCACACCTCAGCACACAGTGAGCTTCACCTGCGAGTCCCACGGCTTCTCACCCAGAGA
CATCACCCTGAAATGGTTCAAAAATGGGAATGAGCTCTCAGACTTCCAGACCAACGTGGACCCCGTAGGAGAGAGCGTGTCCTACAGCATCCACAGCACAGCCAAGGTGGTGCTGACCCGCGAGGACG
TTCACTCTCAAGTCATCTGCGAGGTGGCCCACGTCACCTTGCAGGGGGACCCTCTTCGTGGGACTGCCAACTTGTCTGAGACCATCCGAGTTCCACCCACCTTGGAGGTTACTCAACAGCCCGTGAGG
GCAGAGAACCAGGTGAATGTCACCTGCCAGGTGAGGAAGTTCTACCCCCAGAGACTACAGCTGACCTGGTTGGAGAATGGAAACGTGTCCCGGACAGAAACGGCCTCAACCGTTACAGAGAACAAGGA
TGGTACCTACAACTGGATGAGCTGGCTCCTGGTGAATGTATCTGCCCACAGGGATGATGTGAAGCTCACCTGCCAGGTGGAGCATGACGGGCAGCCAGCGGTCAGCAAAAGCCATGACCTGAAGGTCT
CAGCCCACCCGAAGGAGCAGGGCTCAAATACCGCCGCTGAGAACACTGGATCTAATGAACGGAACATCTATATTGTGGTGGGTGTGGTGTGCACCTTGCTGGTGGCCCTACTGATGGCGGCCCTCTAC
CTCGTCCGAATCAGACAGAAGAAAGCCCAGGGCTCCACTTCTTCTACAAGGTTGCATGAGCCCGAGAAGAATGCCAGAGAAATAACACAGGACACAAATGATATCACATATGCAGACCTGAACCTGCC
CAAGGGGAAGAAGCCTGCTCCCCAGGCTGCGGAGCCCAACAACCACACGGAGTATGCCAGCATTCAGACCAGCCCGCAGCCCGCGTCGGAGGACACCCTCACCTATGCTGACCTGGACATGGTCCACC
TCAACCGGACCCCCAAGCAGCCGGCCCCCAAGCCTGAGCCGTCCTTCTCAGAGTACGCCAGCGTCCAGGTCCCGAGGAAGTGAATGGGACCGTGGTTTGCTCTAGCACCCATCTCTACGCGCTTTCTT
GTCCCACAGGGAGCCGCCGTGATGAGCACAGCCAACCCAGTTCCCGGAGGGCTGGGGCGGTGCAGGCTCTGGGACCCAGGGGCCAGGGTGGCTCTTCTCTCCCCACCCCTCCTTGGCTCTCCAGCACT
TCCTGGGCAGCCACGGCCCCCTCCCCCCACATTGCCACATACCTGGAGGCTGACGTTGCCAAACCAGCCAGGGAACCAACCTGGGAAGTGGCCAGAACTGCCTGGGGTCCAAGAACTCTTGTGCCTCC
GTCCATCACCATGTGGGTTTTGAAGACCCTCGACTGCCTCCCCGATGCTCCGAAGCCTGATCTTCCAGGGTGGGGAGGAGAAAATCCCACCTCCCCTGACCTCCACCACCTCCACCACCACCACCACC
ACCACCACCACCACTACCACCACCACCCAACTGGGGCTAGAGTGGGGAAGATTTCCCCTTTAGATCAAACTGCCCCTTCCATGGAAAAGCTGGAAAAAAACTCTGGAACCCATATCCAGGCTTGGTGA
GGTTGCTGCCAACAGTCCTGGCCTCCCCCATCCCTAGGCTAAAGAGCCATGAGTCCTGGAGGAGGAGAGGACCCCTCCCAAAGGACTGGAGACAAAACCCTCTGCTTCCTTGGGTCCCTCCAAGACTC
CCTGGGGCCCAACTGTGTTGCTCCACCCGGACCCATCTCTCCCTTCTAGACCTGAGCTTGCCCCTCCAGCTAGCACTAAGCAACATCTCGCTGTGGACGCCTGTAAATTACTGAGAAATGTGAAACGT
GCAATCTTGAAACTGAGGTGTTAGAAAACTTGATCTGTGGTGTTTTGTTTTGTTTTTTTTCTTAAAACAACAGCAACGTGATCTTGGCTGTCTGTCATGTGTTGAAGTCCATGGTTGGGTCTTGTGAA
GTCTGAGGTTTAACAGTTTGTTGTCCTGGAGGGATTTTCTTACAGCGAAGACTTGAGTTCCTCCAAGTCCCAGAACCCCAAGAATGGGCAAGAAGGATCAGGTCAGCCACTCCCTGGAGACACAGCCT
TCTGGCTGGGACTGACTTGGCCATGTTCTCAGCTGAGCCACGCGGCTGGTAGTGCAGCCTTCTGTGACCCCGCTGTGGTAAGTCCAGCCTGCCCAGGGCTGCTGAGGGCTGCCTCTTGACAGTGCAGT
CTTATCGAGACCCAATGCCTCAGTCTGCTCATCCGTAAAGTGGGGATAGTGAAGATGACACCCCTCCCCACCACCTCTCATAAGCACTTTAGGAACACACAGAGGGTAGGGATAGTGGCCCTGGCCGT
CTATCCTACCCCTTTAGTGACCGCCCCCATCCCGGCTTTCTGAGCTGATCCTTGAAGAAGAAATCTTCCATTTCTGCTCTCAAACCCTACTGGGATCAAACTGGAATAAATTGAAGACAGCCAGGGGG
ATGGTGCAGCTGTGAAGCTCGGGCTGATTCCCCCTCTGTCCCAGAAGGTTGGCCAGAGGGTGTGACCCAGTTACCCTTTAACCCCCACCCTTCCAGTCGGGTGTGAGGGCCTGACCGGGCCCAGGGCA
AGCAGATGTCGCAAGCCCTATTTATTCAGTCTTCACTATAACTCTTAGAGTTGAGACGCTAATGTTCATGACTCCTGGCCTTGGGATGCCCAAGGGATTTCTGGCTCAGGCTGTAAAAGTAGCTGAGC
CATCCTGCCCATTCCTGGAGGTCCTACAGGTGAAACTGCAGGAGCTCAGCATAGACCCAGCTCTCTGGGGGATGGTCACCTGGTGATTTCAATGATGGCATCCAGGAATTAGCTGAGCCAACAGACCA
TGTGGACAGCTTTGGCCAGAGCTCCCGTGTGGCATCTGGGAGCCACAGTGACCCAGCCACCTGGCTCAGGCTAGTTCCAAATTCCAAAAGATTGGCTTGTAAACCTTCGTCTCCCTCTCTTTTACCCA
GAGACAGCACATACGTGTGCACACGCATGCACACACACATTCAGTATTTTAAAAGAATGTTTTCTTGGTGCCATTTTCATTTTATTTTATTTTTTAATTCTTGGAGGGGGAAATAAGGGAATAAGGCC
AAGGAAGATGTATAGCTTTAGCTTTAGCCTGGCAACCTGGAGAATCCACATACCTTGTGTATTGAACCCCAGGAAAAGGAAGAGGTCGAACCAACCCTGCGGAAGGAGCATGGTTTCAGGAGTTTATT
TTAAGACTGCTGGGAAGGAAACAGGCCCCATTTTGTATATAGTTGCAACTTAAACTTTTTGGCTTGCAAAATATTTTTGTAATAAAGATTTCTGGGTAATAATGA

hide sequence

RefSeq Acc Id:

NM_001040023 ⟹ NP_001035112

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,895,407 - 1,940,592 (+)	NCBI
GRCh37	20	1,874,763 - 1,920,540 (+)	NCBI
Build 36	20	1,823,826 - 1,868,540 (+)	NCBI Archive
HuRef	20	1,824,406 - 1,870,408 (+)	ENTREZGENE
CHM1_1	20	1,876,028 - 1,920,758 (+)	NCBI
T2T-CHM13v2.0	20	1,925,598 - 1,970,769 (+)	NCBI

Sequence:

show sequence

ACTCACGGCCGCTCTCCCTCCTCGCTCCGCAGCCGCGGCCCATGGAGCCCGCCGGCCCGGCCCCCGGCCGCCTCGGGCCGCTGCTCTGCCTGCTGCTCGCCGCGTCCTGCGCCTGGTCAGGAGTGGCG
GGTGAGGAGGAGCTGCAGGTGATTCAGCCTGACAAGTCCGTGTTGGTTGCAGCTGGAGAGACAGCCACTCTGCGCTGCACTGCGACCTCTCTGATCCCTGTGGGGCCCATCCAGTGGTTCAGAGGAGC
TGGACCAGGCCGGGAATTAATCTACAATCAAAAAGAAGGCCACTTCCCCCGGGTAACAACTGTTTCAGACCTCACAAAGAGAAACAACATGGACTTTTCCATCCGCATCGGTAACATCACCCCAGCAG
ATGCCGGCACCTACTACTGTGTGAAGTTCCGGAAAGGGAGCCCCGATGACGTGGAGTTTAAGTCTGGAGCAGGCACTGAGCTGTCTGTGCGCGCCAAACCCTCTGCCCCCGTGGTATCGGGCCCTGCG
GCGAGGGCCACACCTCAGCACACAGTGAGCTTCACCTGCGAGTCCCACGGCTTCTCACCCAGAGACATCACCCTGAAATGGTTCAAAAATGGGAATGAGCTCTCAGACTTCCAGACCAACGTGGACCC
CGTAGGAGAGAGCGTGTCCTACAGCATCCACAGCACAGCCAAGGTGGTGCTGACCCGCGAGGACGTTCACTCTCAAGTCATCTGCGAGGTGGCCCACGTCACCTTGCAGGGGGACCCTCTTCGTGGGA
CTGCCAACTTGTCTGAGACCATCCGAGTTCCACCCACCTTGGAGGTTACTCAACAGCCCGTGAGGGCAGAGAACCAGGTGAATGTCACCTGCCAGGTGAGGAAGTTCTACCCCCAGAGACTACAGCTG
ACCTGGTTGGAGAATGGAAACGTGTCCCGGACAGAAACGGCCTCAACCGTTACAGAGAACAAGGATGGTACCTACAACTGGATGAGCTGGCTCCTGGTGAATGTATCTGCCCACAGGGATGATGTGAA
GCTCACCTGCCAGGTGGAGCATGACGGGCAGCCAGCGGTCAGCAAAAGCCATGACCTGAAGGTCTCAGCCCACCCGAAGGAGCAGGGCTCAAATACCGCCGCTGAGAACACTGGATCTAATGAACGGA
ACATCTATATTGTGGTGGGTGTGGTGTGCACCTTGCTGGTGGCCCTACTGATGGCGGCCCTCTACCTCGTCCGAATCAGACAGAAGAAAGCCCAGGGCTCCACTTCTTCTACAAGGTTGCATGAGCCC
GAGAAGAATGCCAGAGAAATAACACAGGACACAAATGATATCACATATGCAGACCTGAACCTGCCCAAGGGGAAGAAGCCTGCTCCCCAGGCTGCGGAGCCCAACAACCACACGGAGTATGCCAGCAT
TCAGACCAGCCCGCAGCCCGCGTCGGAGGACACCCTCACCTATGCTGACCTGGACATGGTCCACCTCAACCGGACCCCCAAGCAGCCGGCCCCCAAGCCTGAGCCGTCCTTCTCAGAGTACGCCAGCG
TCCAGGTCCCGAGGAAGTGAATGGGACCGTGGTTTGCTCTAGCACCCATCTCTACGCGCTTTCTTGTCCCACAGGGAGCCGCCGTGATGAGCACAGCCAACCCAGTTCCCGGAGGGCTGGGGCGGTGC
AGGCTCTGGGACCCAGGGGCCAGGGTGGCTCTTCTCTCCCCACCCCTCCTTGGCTCTCCAGCACTTCCTGGGCAGCCACGGCCCCCTCCCCCCACATTGCCACATACCTGGAGGCTGACGTTGCCAAA
CCAGCCAGGGAACCAACCTGGGAAGTGGCCAGAACTGCCTGGGGTCCAAGAACTCTTGTGCCTCCGTCCATCACCATGTGGGTTTTGAAGACCCTCGACTGCCTCCCCGATGCTCCGAAGCCTGATCT
TCCAGGGTGGGGAGGAGAAAATCCCACCTCCCCTGACCTCCACCACCTCCACCACCACCACCACCACCACCACCACCACTACCACCACCACCCAACTGGGGCTAGAGTGGGGAAGATTTCCCCTTTAG
ATCAAACTGCCCCTTCCATGGAAAAGCTGGAAAAAAACTCTGGAACCCATATCCAGGCTTGGTGAGGTTGCTGCCAACAGTCCTGGCCTCCCCCATCCCTAGGCTAAAGAGCCATGAGTCCTGGAGGA
GGAGAGGACCCCTCCCAAAGGACTGGAGACAAAACCCTCTGCTTCCTTGGGTCCCTCCAAGACTCCCTGGGGCCCAACTGTGTTGCTCCACCCGGACCCATCTCTCCCTTCTAGACCTGAGCTTGCCC
CTCCAGCTAGCACTAAGCAACATCTCGCTGTGGACGCCTGTAAATTACTGAGAAATGTGAAACGTGCAATCTTGAAACTGAGGTGTTAGAAAACTTGATCTGTGGTGTTTTGTTTTGTTTTTTTTCTT
AAAACAACAGCAACGTGATCTTGGCTGTCTGTCATGTGTTGAAGTCCATGGTTGGGTCTTGTGAAGTCTGAGGTTTAACAGTTTGTTGTCCTGGAGGGATTTTCTTACAGCGAAGACTTGAGTTCCTC
CAAGTCCCAGAACCCCAAGAATGGGCAAGAAGGATCAGGTCAGCCACTCCCTGGAGACACAGCCTTCTGGCTGGGACTGACTTGGCCATGTTCTCAGCTGAGCCACGCGGCTGGTAGTGCAGCCTTCT
GTGACCCCGCTGTGGTAAGTCCAGCCTGCCCAGGGCTGCTGAGGGCTGCCTCTTGACAGTGCAGTCTTATCGAGACCCAATGCCTCAGTCTGCTCATCCGTAAAGTGGGGATAGTGAAGATGACACCC
CTCCCCACCACCTCTCATAAGCACTTTAGGAACACACAGAGGGTAGGGATAGTGGCCCTGGCCGTCTATCCTACCCCTTTAGTGACCGCCCCCATCCCGGCTTTCTGAGCTGATCCTTGAAGAAGAAA
TCTTCCATTTCTGCTCTCAAACCCTACTGGGATCAAACTGGAATAAATTGAAGACAGCCAGGGGGATGGTGCAGCTGTGAAGCTCGGGCTGATTCCCCCTCTGTCCCAGAAGGTTGGCCAGAGGGTGT
GACCCAGTTACCCTTTAACCCCCACCCTTCCAGTCGGGTGTGAGGGCCTGACCGGGCCCAGGGCAAGCAGATGTCGCAAGCCCTATTTATTCAGTCTTCACTATAACTCTTAGAGTTGAGACGCTAAT
GTTCATGACTCCTGGCCTTGGGATGCCCAAGGGATTTCTGGCTCAGGCTGTAAAAGTAGCTGAGCCATCCTGCCCATTCCTGGAGGTCCTACAGGTGAAACTGCAGGAGCTCAGCATAGACCCAGCTC
TCTGGGGGATGGTCACCTGGTGATTTCAATGATGGCATCCAGGAATTAGCTGAGCCAACAGACCATGTGGACAGCTTTGGCCAGAGCTCCCGTGTGGCATCTGGGAGCCACAGTGACCCAGCCACCTG
GCTCAGGCTAGTTCCAAATTCCAAAAGATTGGCTTGTAAACCTTCGTCTCCCTCTCTTTTACCCAGAGACAGCACATACGTGTGCACACGCATGCACACACACATTCAGTATTTTAAAAGAATGTTTT
CTTGGTGCCATTTTCATTTTATTTTATTTTTTAATTCTTGGAGGGGGAAATAAGGGAATAAGGCCAAGGAAGATGTATAGCTTTAGCTTTAGCCTGGCAACCTGGAGAATCCACATACCTTGTGTATT
GAACCCCAGGAAAAGGAAGAGGTCGAACCAACCCTGCGGAAGGAGCATGGTTTCAGGAGTTTATTTTAAGACTGCTGGGAAGGAAACAGGCCCCATTTTGTATATAGTTGCAACTTAAACTTTTTGGC
TTGCAAAATATTTTTGTAATAAAGATTTCTGGGTAATAATGAGTCCTTCCGGTGTTCAGTATTCTTGTCTTTGTGAGTGCGTCCCGGGGCCGCCTCGGGGCCTGCCTGCCCTCCTGCCAAAGCCTGGA
AGAGGATTGAATGGACCCCAGGGTTTGGAAACAACCTACAGCATTTGAGCCCCTCACGTAGGTTTTAGAGACGTACAATTTTTGTTTGCCCTGGCTCAGAAGGAGCCGGTGTAAGGTTGAGATAAAAT
TCCATATAGACAACTGAGTTTGGATCTCGGCTCTGCTGCTTTGTAGCTGTGGGAGTTCAAACAGCACCTCTTTGAGACTTGGGCCCCGCGTCGGCACAATGGGGCAGGAATAGTCCCTGCCAGGGTGA
CTGTGTGGATTCAAGGAGGTTGGAAGCACTGAGCCCACGCTTGGCACTGGGTAGGCCATCACTGAGGCTTGTGTCTTTCCTTCCTGCCCTGACCCTGCATAGCTGAGTCTCGTGGCCTCTCACCACTG
ATGGGATCTCGGACACCCGGCTCACCCTCCTCCTGGGGCCTCACTTTCCTTCCCCACCAAATGCAGACATCTAATGCTTGTCCTGTAATATCCTTGCCAGATGACTGATGTCAAGTGCTGGTTTATAG
TGGGTGCTCAATAAATGTTAGTTTCCTTTCTATCCCTCCATTAGATCATTAATGATATTAGTGCTAATTATGTAATAAAGTTAAGGCATAAATATGTTAA

hide sequence

RefSeq Acc Id:

NM_001330728 ⟹ NP_001317657

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,167 - 1,939,894 (+)	NCBI
T2T-CHM13v2.0	20	1,924,358 - 1,970,071 (+)	NCBI

Sequence:

show sequence

TCCGGCCCGCACCCACCCCCAAGAGGGGCCTTCAGCTTTGGGGCTCAGAGGCACGACCTCCTGGGGAGGGTTAAAAGGCAGACGCCCCCCCGCCCCCCGCGCCCCCGCGCCCCGACTCCTTCGCCGCC
TCCAGCCTCTCGCCAGTGGGAAGCGGGGAGCAGCCGCGCGGCCGGAGTCCGGAGGCGAGGGGAGGTCGGCCGCAACTTCCCCGGTCCACCTTAAGAGGACGATGTAGCCAGCTCGCAGCGCTGACCTT
AGAAAAACAAGTTTGCGCAAAGTGGAGCGGGGACCCGGCCTCTGGGCAGCCCCGGCGGCGCTTCCAGTGCCTTCCAGCCCTCGCGGGCGGCGCAGCCGCGGCCCATGGAGCCCGCCGGCCCGGCCCCC
GGCCGCCTCGGGCCGCTGCTCTGCCTGCTGCTCGCCGCGTCCTGCGCCTGGTCAGGAGTGGCGGGTGAGGAGGAGCTGCAGGTGATTCAGCCTGACAAGTCCGTGTTGGTTGCAGCTGGAGAGACAGC
CACTCTGCGCTGCACTGCGACCTCTCTGATCCCTGTGGGGCCCATCCAGTGGTTCAGAGGAGCTGGACCAGGCCGGGAATTAATCTACAATCAAAAAGAAGGCCACTTCCCCCGGGTAACAACTGTTT
CAGACCTCACAAAGAGAAACAACATGGACTTTTCCATCCGCATCGGTAACATCACCCCAGCAGATGCCGGCACCTACTACTGTGTGAAGTTCCGGAAAGGGAGCCCCGATGACGTGGAGTTTAAGTCT
GGAGCAGGCACTGAGCTGTCTGTGCGCGCCAAACCCTCTGCCCCCGTGGTATCGGGCCCTGCGGCGAGGGCCACACCTCAGCACACAGTGAGCTTCACCTGCGAGTCCCACGGCTTCTCACCCAGAGA
CATCACCCTGAAATGGTTCAAAAATGGGAATGAGCTCTCAGACTTCCAGACCAACGTGGACCCCGTAGGAGAGAGCGTGTCCTACAGCATCCACAGCACAGCCAAGGTGGTGCTGACCCGCGAGGACG
TTCACTCTCAAGTCATCTGCGAGGTGGCCCACGTCACCTTGCAGGGGGACCCTCTTCGTGGGACTGCCAACTTGTCTGAGACCATCCGAGTTCCACCCACCTTGGAGGTTACTCAACAGCCCGTGAGG
GCAGAGAACCAGGTGAATGTCACCTGCCAGGTGAGGAAGTTCTACCCCCAGAGACTACAGCTGACCTGGTTGGAGAATGGAAACGTGTCCCGGACAGAAACGGCCTCAACCGTTACAGAGAACAAGGA
TGGTACCTACAACTGGATGAGCTGGCTCCTGGTGAATGTATCTGCCCACAGGGATGATGTGAAGCTCACCTGCCAGGTGGAGCATGACGGGCAGCCAGCGGTCAGCAAAAGCCATGACCTGAAGGTCT
CAGCCCACCCGAAGGAGCAGGGCTCAAATACCGCCGCTGAGAACACTGGATCTAATGAACGGAACATCTATATTGTGGTGGGTGTGGTGTGCACCTTGCTGGTGGCCCTACTGATGGCGGCCCTCTAC
CTCGTCCGAATCAGACAGAAGAAAGCCCAGGGCTCCACTTCTTCTACAAGGTTGCATGAGCCCGAGAAGAATGCCAGAGAAATAACACAGGTACAGTCCTTGGACACAAATGATATCACATATGCAGA
CCTGAACCTGCCCAAGGGGAAGAAGCCTGCTCCCCAGGCTGCGGAGCCCAACAACCACACGGAGTATGCCAGCATTCAGACCAGCCCGCAGCCCGCGTCGGAGGACACCCTCACCTATGCTGACCTGG
ACATGGTCCACCTCAACCGGACCCCCAAGCAGCCGGCCCCCAAGCCTGAGCCGTCCTTCTCAGAGTACGCCAGCGTCCAGGTCCCGAGGAAGTGAATGGGACCGTGGTTTGCTCTAGCACCCATCTCT
ACGCGCTTTCTTGTCCCACAGGGAGCCGCCGTGATGAGCACAGCCAACCCAGTTCCCGGAGGGCTGGGGCGGTGCAGGCTCTGGGACCCAGGGGCCAGGGTGGCTCTTCTCTCCCCACCCCTCCTTGG
CTCTCCAGCACTTCCTGGGCAGCCACGGCCCCCTCCCCCCACATTGCCACATACCTGGAGGCTGACGTTGCCAAACCAGCCAGGGAACCAACCTGGGAAGTGGCCAGAACTGCCTGGGGTCCAAGAAC
TCTTGTGCCTCCGTCCATCACCATGTGGGTTTTGAAGACCCTCGACTGCCTCCCCGATGCTCCGAAGCCTGATCTTCCAGGGTGGGGAGGAGAAAATCCCACCTCCCCTGACCTCCACCACCTCCACC
ACCACCACCACCACCACCACCACCACTACCACCACCACCCAACTGGGGCTAGAGTGGGGAAGATTTCCCCTTTAGATCAAACTGCCCCTTCCATGGAAAAGCTGGAAAAAAACTCTGGAACCCATATC
CAGGCTTGGTGAGGTTGCTGCCAACAGTCCTGGCCTCCCCCATCCCTAGGCTAAAGAGCCATGAGTCCTGGAGGAGGAGAGGACCCCTCCCAAAGGACTGGAGACAAAACCCTCTGCTTCCTTGGGTC
CCTCCAAGACTCCCTGGGGCCCAACTGTGTTGCTCCACCCGGACCCATCTCTCCCTTCTAGACCTGAGCTTGCCCCTCCAGCTAGCACTAAGCAACATCTCGCTGTGGACGCCTGTAAATTACTGAGA
AATGTGAAACGTGCAATCTTGAAACTGAGGTGTTAGAAAACTTGATCTGTGGTGTTTTGTTTTGTTTTTTTTCTTAAAACAACAGCAACGTGATCTTGGCTGTCTGTCATGTGTTGAAGTCCATGGTT
GGGTCTTGTGAAGTCTGAGGTTTAACAGTTTGTTGTCCTGGAGGGATTTTCTTACAGCGAAGACTTGAGTTCCTCCAAGTCCCAGAACCCCAAGAATGGGCAAGAAGGATCAGGTCAGCCACTCCCTG
GAGACACAGCCTTCTGGCTGGGACTGACTTGGCCATGTTCTCAGCTGAGCCACGCGGCTGGTAGTGCAGCCTTCTGTGACCCCGCTGTGGTAAGTCCAGCCTGCCCAGGGCTGCTGAGGGCTGCCTCT
TGACAGTGCAGTCTTATCGAGACCCAATGCCTCAGTCTGCTCATCCGTAAAGTGGGGATAGTGAAGATGACACCCCTCCCCACCACCTCTCATAAGCACTTTAGGAACACACAGAGGGTAGGGATAGT
GGCCCTGGCCGTCTATCCTACCCCTTTAGTGACCGCCCCCATCCCGGCTTTCTGAGCTGATCCTTGAAGAAGAAATCTTCCATTTCTGCTCTCAAACCCTACTGGGATCAAACTGGAATAAATTGAAG
ACAGCCAGGGGGATGGTGCAGCTGTGAAGCTCGGGCTGATTCCCCCTCTGTCCCAGAAGGTTGGCCAGAGGGTGTGACCCAGTTACCCTTTAACCCCCACCCTTCCAGTCGGGTGTGAGGGCCTGACC
GGGCCCAGGGCAAGCAGATGTCGCAAGCCCTATTTATTCAGTCTTCACTATAACTCTTAGAGTTGAGACGCTAATGTTCATGACTCCTGGCCTTGGGATGCCCAAGGGATTTCTGGCTCAGGCTGTAA
AAGTAGCTGAGCCATCCTGCCCATTCCTGGAGGTCCTACAGGTGAAACTGCAGGAGCTCAGCATAGACCCAGCTCTCTGGGGGATGGTCACCTGGTGATTTCAATGATGGCATCCAGGAATTAGCTGA
GCCAACAGACCATGTGGACAGCTTTGGCCAGAGCTCCCGTGTGGCATCTGGGAGCCACAGTGACCCAGCCACCTGGCTCAGGCTAGTTCCAAATTCCAAAAGATTGGCTTGTAAACCTTCGTCTCCCT
CTCTTTTACCCAGAGACAGCACATACGTGTGCACACGCATGCACACACACATTCAGTATTTTAAAAGAATGTTTTCTTGGTGCCATTTTCATTTTATTTTATTTTTTAATTCTTGGAGGGGGAAATAA
GGGAATAAGGCCAAGGAAGATGTATAGCTTTAGCTTTAGCCTGGCAACCTGGAGAATCCACATACCTTGTGTATTGAACCCCAGGAAAAGGAAGAGGTCGAACCAACCCTGCGGAAGGAGCATGGTTT
CAGGAGTTTATTTTAAGACTGCTGGGAAGGAAACAGGCCCCATTTTGTATATAGTTGCAACTTAAACTTTTTGGCTTGCAAAATATTTTTGTAATAAAGATTTCTGGGTAATAATGA

hide sequence

RefSeq Acc Id:

NM_080792 ⟹ NP_542970

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,742 - 1,940,592 (+)	NCBI
GRCh37	20	1,874,763 - 1,920,540 (+)	NCBI
Build 36	20	1,823,425 - 1,868,540 (+)	NCBI Archive
HuRef	20	1,824,406 - 1,870,408 (+)	ENTREZGENE
CHM1_1	20	1,875,627 - 1,920,758 (+)	NCBI
T2T-CHM13v2.0	20	1,924,933 - 1,970,769 (+)	NCBI

Sequence:

show sequence

GCAGCCCTCGCTCCCTCCCCCGGGGCGCGCAGGCGGGCGCTCGCTCGCAGAGAAGCCGCGGCCCATGGAGCCCGCCGGCCCGGCCCCCGGCCGCCTCGGGCCGCTGCTCTGCCTGCTGCTCGCCGCGT
CCTGCGCCTGGTCAGGAGTGGCGGGTGAGGAGGAGCTGCAGGTGATTCAGCCTGACAAGTCCGTGTTGGTTGCAGCTGGAGAGACAGCCACTCTGCGCTGCACTGCGACCTCTCTGATCCCTGTGGGG
CCCATCCAGTGGTTCAGAGGAGCTGGACCAGGCCGGGAATTAATCTACAATCAAAAAGAAGGCCACTTCCCCCGGGTAACAACTGTTTCAGACCTCACAAAGAGAAACAACATGGACTTTTCCATCCG
CATCGGTAACATCACCCCAGCAGATGCCGGCACCTACTACTGTGTGAAGTTCCGGAAAGGGAGCCCCGATGACGTGGAGTTTAAGTCTGGAGCAGGCACTGAGCTGTCTGTGCGCGCCAAACCCTCTG
CCCCCGTGGTATCGGGCCCTGCGGCGAGGGCCACACCTCAGCACACAGTGAGCTTCACCTGCGAGTCCCACGGCTTCTCACCCAGAGACATCACCCTGAAATGGTTCAAAAATGGGAATGAGCTCTCA
GACTTCCAGACCAACGTGGACCCCGTAGGAGAGAGCGTGTCCTACAGCATCCACAGCACAGCCAAGGTGGTGCTGACCCGCGAGGACGTTCACTCTCAAGTCATCTGCGAGGTGGCCCACGTCACCTT
GCAGGGGGACCCTCTTCGTGGGACTGCCAACTTGTCTGAGACCATCCGAGTTCCACCCACCTTGGAGGTTACTCAACAGCCCGTGAGGGCAGAGAACCAGGTGAATGTCACCTGCCAGGTGAGGAAGT
TCTACCCCCAGAGACTACAGCTGACCTGGTTGGAGAATGGAAACGTGTCCCGGACAGAAACGGCCTCAACCGTTACAGAGAACAAGGATGGTACCTACAACTGGATGAGCTGGCTCCTGGTGAATGTA
TCTGCCCACAGGGATGATGTGAAGCTCACCTGCCAGGTGGAGCATGACGGGCAGCCAGCGGTCAGCAAAAGCCATGACCTGAAGGTCTCAGCCCACCCGAAGGAGCAGGGCTCAAATACCGCCGCTGA
GAACACTGGATCTAATGAACGGAACATCTATATTGTGGTGGGTGTGGTGTGCACCTTGCTGGTGGCCCTACTGATGGCGGCCCTCTACCTCGTCCGAATCAGACAGAAGAAAGCCCAGGGCTCCACTT
CTTCTACAAGGTTGCATGAGCCCGAGAAGAATGCCAGAGAAATAACACAGGACACAAATGATATCACATATGCAGACCTGAACCTGCCCAAGGGGAAGAAGCCTGCTCCCCAGGCTGCGGAGCCCAAC
AACCACACGGAGTATGCCAGCATTCAGACCAGCCCGCAGCCCGCGTCGGAGGACACCCTCACCTATGCTGACCTGGACATGGTCCACCTCAACCGGACCCCCAAGCAGCCGGCCCCCAAGCCTGAGCC
GTCCTTCTCAGAGTACGCCAGCGTCCAGGTCCCGAGGAAGTGAATGGGACCGTGGTTTGCTCTAGCACCCATCTCTACGCGCTTTCTTGTCCCACAGGGAGCCGCCGTGATGAGCACAGCCAACCCAG
TTCCCGGAGGGCTGGGGCGGTGCAGGCTCTGGGACCCAGGGGCCAGGGTGGCTCTTCTCTCCCCACCCCTCCTTGGCTCTCCAGCACTTCCTGGGCAGCCACGGCCCCCTCCCCCCACATTGCCACAT
ACCTGGAGGCTGACGTTGCCAAACCAGCCAGGGAACCAACCTGGGAAGTGGCCAGAACTGCCTGGGGTCCAAGAACTCTTGTGCCTCCGTCCATCACCATGTGGGTTTTGAAGACCCTCGACTGCCTC
CCCGATGCTCCGAAGCCTGATCTTCCAGGGTGGGGAGGAGAAAATCCCACCTCCCCTGACCTCCACCACCTCCACCACCACCACCACCACCACCACCACCACTACCACCACCACCCAACTGGGGCTAG
AGTGGGGAAGATTTCCCCTTTAGATCAAACTGCCCCTTCCATGGAAAAGCTGGAAAAAAACTCTGGAACCCATATCCAGGCTTGGTGAGGTTGCTGCCAACAGTCCTGGCCTCCCCCATCCCTAGGCT
AAAGAGCCATGAGTCCTGGAGGAGGAGAGGACCCCTCCCAAAGGACTGGAGACAAAACCCTCTGCTTCCTTGGGTCCCTCCAAGACTCCCTGGGGCCCAACTGTGTTGCTCCACCCGGACCCATCTCT
CCCTTCTAGACCTGAGCTTGCCCCTCCAGCTAGCACTAAGCAACATCTCGCTGTGGACGCCTGTAAATTACTGAGAAATGTGAAACGTGCAATCTTGAAACTGAGGTGTTAGAAAACTTGATCTGTGG
TGTTTTGTTTTGTTTTTTTTCTTAAAACAACAGCAACGTGATCTTGGCTGTCTGTCATGTGTTGAAGTCCATGGTTGGGTCTTGTGAAGTCTGAGGTTTAACAGTTTGTTGTCCTGGAGGGATTTTCT
TACAGCGAAGACTTGAGTTCCTCCAAGTCCCAGAACCCCAAGAATGGGCAAGAAGGATCAGGTCAGCCACTCCCTGGAGACACAGCCTTCTGGCTGGGACTGACTTGGCCATGTTCTCAGCTGAGCCA
CGCGGCTGGTAGTGCAGCCTTCTGTGACCCCGCTGTGGTAAGTCCAGCCTGCCCAGGGCTGCTGAGGGCTGCCTCTTGACAGTGCAGTCTTATCGAGACCCAATGCCTCAGTCTGCTCATCCGTAAAG
TGGGGATAGTGAAGATGACACCCCTCCCCACCACCTCTCATAAGCACTTTAGGAACACACAGAGGGTAGGGATAGTGGCCCTGGCCGTCTATCCTACCCCTTTAGTGACCGCCCCCATCCCGGCTTTC
TGAGCTGATCCTTGAAGAAGAAATCTTCCATTTCTGCTCTCAAACCCTACTGGGATCAAACTGGAATAAATTGAAGACAGCCAGGGGGATGGTGCAGCTGTGAAGCTCGGGCTGATTCCCCCTCTGTC
CCAGAAGGTTGGCCAGAGGGTGTGACCCAGTTACCCTTTAACCCCCACCCTTCCAGTCGGGTGTGAGGGCCTGACCGGGCCCAGGGCAAGCAGATGTCGCAAGCCCTATTTATTCAGTCTTCACTATA
ACTCTTAGAGTTGAGACGCTAATGTTCATGACTCCTGGCCTTGGGATGCCCAAGGGATTTCTGGCTCAGGCTGTAAAAGTAGCTGAGCCATCCTGCCCATTCCTGGAGGTCCTACAGGTGAAACTGCA
GGAGCTCAGCATAGACCCAGCTCTCTGGGGGATGGTCACCTGGTGATTTCAATGATGGCATCCAGGAATTAGCTGAGCCAACAGACCATGTGGACAGCTTTGGCCAGAGCTCCCGTGTGGCATCTGGG
AGCCACAGTGACCCAGCCACCTGGCTCAGGCTAGTTCCAAATTCCAAAAGATTGGCTTGTAAACCTTCGTCTCCCTCTCTTTTACCCAGAGACAGCACATACGTGTGCACACGCATGCACACACACAT
TCAGTATTTTAAAAGAATGTTTTCTTGGTGCCATTTTCATTTTATTTTATTTTTTAATTCTTGGAGGGGGAAATAAGGGAATAAGGCCAAGGAAGATGTATAGCTTTAGCTTTAGCCTGGCAACCTGG
AGAATCCACATACCTTGTGTATTGAACCCCAGGAAAAGGAAGAGGTCGAACCAACCCTGCGGAAGGAGCATGGTTTCAGGAGTTTATTTTAAGACTGCTGGGAAGGAAACAGGCCCCATTTTGTATAT
AGTTGCAACTTAAACTTTTTGGCTTGCAAAATATTTTTGTAATAAAGATTTCTGGGTAATAATGAGTCCTTCCGGTGTTCAGTATTCTTGTCTTTGTGAGTGCGTCCCGGGGCCGCCTCGGGGCCTGC
CTGCCCTCCTGCCAAAGCCTGGAAGAGGATTGAATGGACCCCAGGGTTTGGAAACAACCTACAGCATTTGAGCCCCTCACGTAGGTTTTAGAGACGTACAATTTTTGTTTGCCCTGGCTCAGAAGGAG
CCGGTGTAAGGTTGAGATAAAATTCCATATAGACAACTGAGTTTGGATCTCGGCTCTGCTGCTTTGTAGCTGTGGGAGTTCAAACAGCACCTCTTTGAGACTTGGGCCCCGCGTCGGCACAATGGGGC
AGGAATAGTCCCTGCCAGGGTGACTGTGTGGATTCAAGGAGGTTGGAAGCACTGAGCCCACGCTTGGCACTGGGTAGGCCATCACTGAGGCTTGTGTCTTTCCTTCCTGCCCTGACCCTGCATAGCTG
AGTCTCGTGGCCTCTCACCACTGATGGGATCTCGGACACCCGGCTCACCCTCCTCCTGGGGCCTCACTTTCCTTCCCCACCAAATGCAGACATCTAATGCTTGTCCTGTAATATCCTTGCCAGATGAC
TGATGTCAAGTGCTGGTTTATAGTGGGTGCTCAATAAATGTTAGTTTCCTTTCTATCCCTCCATTAGATCATTAATGATATTAGTGCTAATTATGTAATAAAGTTAAGGCATAAATATGTTAA

hide sequence

RefSeq Acc Id:

XM_005260670 ⟹ XP_005260727

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,742 - 1,940,592 (+)	NCBI
GRCh37	20	1,874,763 - 1,920,540 (+)	NCBI

Sequence:

show sequence

GCTCGCTCGCAGAGAAGCCGCGGCCCATGGAGCCCGCCGGCCCGGCCCCCGGCCGCCTCGGGCCGCTGCTCTGCCTGCTGCTCGCCGCGTCCTGCGCCTGGTCAGGAGTGGCGGGTGAGGAGGAGCTG
CAGGTGATTCAGCCTGACAAGTCCGTGTTGGTTGCAGCTGGAGAGACAGCCACTCTGCGCTGCACTGCGACCTCTCTGATCCCTGTGGGGCCCATCCAGTGGTTCAGAGGAGCTGGACCAGGCCGGGA
ATTAATCTACAATCAAAAAGAAGGCCACTTCCCCCGGGTAACAACTGTTTCAGACCTCACAAAGAGAAACAACATGGACTTTTCCATCCGCATCGGTAACATCACCCCAGCAGATGCCGGCACCTACT
ACTGTGTGAAGTTCCGGAAAGGGAGCCCCGATGACGTGGAGTTTAAGTCTGGAGCAGGCACTGAGCTGTCTGTGCGCGCCAAACCCTCTGCCCCCGTGGTATCGGGCCCTGCGGCGAGGGCCACACCT
CAGCACACAGTGAGCTTCACCTGCGAGTCCCACGGCTTCTCACCCAGAGACATCACCCTGAAATGGTTCAAAAATGGGAATGAGCTCTCAGACTTCCAGACCAACGTGGACCCCGTAGGAGAGAGCGT
GTCCTACAGCATCCACAGCACAGCCAAGGTGGTGCTGACCCGCGAGGACGTTCACTCTCAAGTCATCTGCGAGGTGGCCCACGTCACCTTGCAGGGGGACCCTCTTCGTGGGACTGCCAACTTGTCTG
AGACCATCCGAGTTCCACCCACCTTGGAGGTTACTCAACAGCCCGTGAGGGCAGAGAACCAGGTGAATGTCACCTGCCAGGTGAGGAAGTTCTACCCCCAGAGACTACAGCTGACCTGGTTGGAGAAT
GGAAACGTGTCCCGGACAGAAACGGCCTCAACCGTTACAGAGAACAAGGATGGTACCTACAACTGGATGAGCTGGCTCCTGGTGAATGTATCTGCCCACAGGGATGATGTGAAGCTCACCTGCCAGGT
GGAGCATGACGGGCAGCCAGCGGTCAGCAAAAGCCATGACCTGAAGGTCTCAGCCCACCCGAAGGAGCAGGGCTCAAATACCGCCGCTGAGAACACTGGATCTAATGAACGGAACATCTATATTGTGG
TGGGTGTGGTGTGCACCTTGCTGGTGGCCCTACTGATGGCGGCCCTCTACCTCGTCCGAATCAGACAGAAGAAAGCCCAGGGCTCCACTTCTTCTACAAGGTTGCATGAGCCCGAGAAGAATGCCAGA
GAAATAACACAGGTACAGTCCTTGGACACAAATGATATCACATATGCAGACCTGAACCTGCCCAAGGGGAAGAAGCCTGCTCCCCAGGCTGCGGAGCCCAACAACCACACGGAGTATGCCAGCATTCA
GACCAGCCCGCAGCCCGCGTCGGAGGACACCCTCACCTATGCTGACCTGGACATGGTCCACCTCAACCGGACCCCCAAGCAGCCGGCCCCCAAGCCTGAGCCGTCCTTCTCAGAGTACGCCAGCGTCC
AGGTCCCGAGGAAGTGAATGGGACCGTGGTTTGCTCTAGCACCCATCTCTACGCGCTTTCTTGTCCCACAGGGAGCCGCCGTGATGAGCACAGCCAACCCAGTTCCCGGAGGGCTGGGGCGGTGCAGG
CTCTGGGACCCAGGGGCCAGGGTGGCTCTTCTCTCCCCACCCCTCCTTGGCTCTCCAGCACTTCCTGGGCAGCCACGGCCCCCTCCCCCCACATTGCCACATACCTGGAGGCTGACGTTGCCAAACCA
GCCAGGGAACCAACCTGGGAAGTGGCCAGAACTGCCTGGGGTCCAAGAACTCTTGTGCCTCCGTCCATCACCATGTGGGTTTTGAAGACCCTCGACTGCCTCCCCGATGCTCCGAAGCCTGATCTTCC
AGGGTGGGGAGGAGAAAATCCCACCTCCCCTGACCTCCACCACCTCCACCACCACCACCACCACCACCACCACCACTACCACCACCACCCAACTGGGGCTAGAGTGGGGAAGATTTCCCCTTTAGATC
AAACTGCCCCTTCCATGGAAAAGCTGGAAAAAAACTCTGGAACCCATATCCAGGCTTGGTGAGGTTGCTGCCAACAGTCCTGGCCTCCCCCATCCCTAGGCTAAAGAGCCATGAGTCCTGGAGGAGGA
GAGGACCCCTCCCAAAGGACTGGAGACAAAACCCTCTGCTTCCTTGGGTCCCTCCAAGACTCCCTGGGGCCCAACTGTGTTGCTCCACCCGGACCCATCTCTCCCTTCTAGACCTGAGCTTGCCCCTC
CAGCTAGCACTAAGCAACATCTCGCTGTGGACGCCTGTAAATTACTGAGAAATGTGAAACGTGCAATCTTGAAACTGAGGTGTTAGAAAACTTGATCTGTGGTGTTTTGTTTTGTTTTTTTTCTTAAA
ACAACAGCAACGTGATCTTGGCTGTCTGTCATGTGTTGAAGTCCATGGTTGGGTCTTGTGAAGTCTGAGGTTTAACAGTTTGTTGTCCTGGAGGGATTTTCTTACAGCGAAGACTTGAGTTCCTCCAA
GTCCCAGAACCCCAAGAATGGGCAAGAAGGATCAGGTCAGCCACTCCCTGGAGACACAGCCTTCTGGCTGGGACTGACTTGGCCATGTTCTCAGCTGAGCCACGCGGCTGGTAGTGCAGCCTTCTGTG
ACCCCGCTGTGGTAAGTCCAGCCTGCCCAGGGCTGCTGAGGGCTGCCTCTTGACAGTGCAGTCTTATCGAGACCCAATGCCTCAGTCTGCTCATCCGTAAAGTGGGGATAGTGAAGATGACACCCCTC
CCCACCACCTCTCATAAGCACTTTAGGAACACACAGAGGGTAGGGATAGTGGCCCTGGCCGTCTATCCTACCCCTTTAGTGACCGCCCCCATCCCGGCTTTCTGAGCTGATCCTTGAAGAAGAAATCT
TCCATTTCTGCTCTCAAACCCTACTGGGATCAAACTGGAATAAATTGAAGACAGCCAGGGGGATGGTGCAGCTGTGAAGCTCGGGCTGATTCCCCCTCTGTCCCAGAAGGTTGGCCAGAGGGTGTGAC
CCAGTTACCCTTTAACCCCCACCCTTCCAGTCGGGTGTGAGGGCCTGACCGGGCCCAGGGCAAGCAGATGTCGCAAGCCCTATTTATTCAGTCTTCACTATAACTCTTAGAGTTGAGACGCTAATGTT
CATGACTCCTGGCCTTGGGATGCCCAAGGGATTTCTGGCTCAGGCTGTAAAAGTAGCTGAGCCATCCTGCCCATTCCTGGAGGTCCTACAGGTGAAACTGCAGGAGCTCAGCATAGACCCAGCTCTCT
GGGGGATGGTCACCTGGTGATTTCAATGATGGCATCCAGGAATTAGCTGAGCCAACAGACCATGTGGACAGCTTTGGCCAGAGCTCCCGTGTGGCATCTGGGAGCCACAGTGACCCAGCCACCTGGCT
CAGGCTAGTTCCAAATTCCAAAAGATTGGCTTGTAAACCTTCGTCTCCCTCTCTTTTACCCAGAGACAGCACATACGTGTGCACACGCATGCACACACACATTCAGTATTTTAAAAGAATGTTTTCTT
GGTGCCATTTTCATTTTATTTTATTTTTTAATTCTTGGAGGGGGAAATAAGGGAATAAGGCCAAGGAAGATGTATAGCTTTAGCTTTAGCCTGGCAACCTGGAGAATCCACATACCTTGTGTATTGAA
CCCCAGGAAAAGGAAGAGGTCGAACCAACCCTGCGGAAGGAGCATGGTTTCAGGAGTTTATTTTAAGACTGCTGGGAAGGAAACAGGCCCCATTTTGTATATAGTTGCAACTTAAACTTTTTGGCTTG
CAAAATATTTTTGTAATAAAGATTTCTGGGTAATAATGAG

hide sequence

RefSeq Acc Id:

XM_011529173 ⟹ XP_011527475

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,896,839 - 1,940,592 (+)	NCBI

Sequence:

show sequence

TTCAAACCAGGTCCGATGACTCTAAAGACCAGATGCTGCATTTGGACGCTGTCCCCAGCCTTGG
CTTATTTTATCCTCCCAGAGATCCATCGAGGAGTGGCGGGTGAGGAGGAGCTGCAGGTGATTCAGCCTGACAAGTCCGTGTTGGTTGCAGCTGGAGAGACAGCCACTCTGCGCTGCACTGCGACCTCT
CTGATCCCTGTGGGGCCCATCCAGTGGTTCAGAGGAGCTGGACCAGGCCGGGAATTAATCTACAATCAAAAAGAAGGCCACTTCCCCCGGGTAACAACTGTTTCAGACCTCACAAAGAGAAACAACAT
GGACTTTTCCATCCGCATCGGTAACATCACCCCAGCAGATGCCGGCACCTACTACTGTGTGAAGTTCCGGAAAGGGAGCCCCGATGACGTGGAGTTTAAGTCTGGAGCAGGCACTGAGCTGTCTGTGC
GCGCCAAACCCTCTGCCCCCGTGGTATCGGGCCCTGCGGCGAGGGCCACACCTCAGCACACAGTGAGCTTCACCTGCGAGTCCCACGGCTTCTCACCCAGAGACATCACCCTGAAATGGTTCAAAAAT
GGGAATGAGCTCTCAGACTTCCAGACCAACGTGGACCCCGTAGGAGAGAGCGTGTCCTACAGCATCCACAGCACAGCCAAGGTGGTGCTGACCCGCGAGGACGTTCACTCTCAAGTCATCTGCGAGGT
GGCCCACGTCACCTTGCAGGGGGACCCTCTTCGTGGGACTGCCAACTTGTCTGAGACCATCCGAGTTCCACCCACCTTGGAGGTTACTCAACAGCCCGTGAGGGCAGAGAACCAGGTGAATGTCACCT
GCCAGGTGAGGAAGTTCTACCCCCAGAGACTACAGCTGACCTGGTTGGAGAATGGAAACGTGTCCCGGACAGAAACGGCCTCAACCGTTACAGAGAACAAGGATGGTACCTACAACTGGATGAGCTGG
CTCCTGGTGAATGTATCTGCCCACAGGGATGATGTGAAGCTCACCTGCCAGGTGGAGCATGACGGGCAGCCAGCGGTCAGCAAAAGCCATGACCTGAAGGTCTCAGCCCACCCGAAGGAGCAGGGCTC
AAATACCGCCGCTGAGAACACTGGATCTAATGAACGGAACATCTATATTGTGGTGGGTGTGGTGTGCACCTTGCTGGTGGCCCTACTGATGGCGGCCCTCTACCTCGTCCGAATCAGACAGAAGAAAG
CCCAGGGCTCCACTTCTTCTACAAGGTTGCATGAGCCCGAGAAGAATGCCAGAGAAATAACACAGGTACAGTCCTTGGACACAAATGATATCACATATGCAGACCTGAACCTGCCCAAGGGGAAGAAG
CCTGCTCCCCAGGCTGCGGAGCCCAACAACCACACGGAGTATGCCAGCATTCAGACCAGCCCGCAGCCCGCGTCGGAGGACACCCTCACCTATGCTGACCTGGACATGGTCCACCTCAACCGGACCCC
CAAGCAGCCGGCCCCCAAGCCTGAGCCGTCCTTCTCAGAGTACGCCAGCGTCCAGGTCCCGAGGAAGTGAATGGGACCGTGGTTTGCTCTAGCACCCATCTCTACGCGCTTTCTTGTCCCACAGGGAG
CCGCCGTGATGAGCACAGCCAACCCAGTTCCCGGAGGGCTGGGGCGGTGCAGGCTCTGGGACCCAGGGGCCAGGGTGGCTCTTCTCTCCCCACCCCTCCTTGGCTCTCCAGCACTTCCTGGGCAGCCA
CGGCCCCCTCCCCCCACATTGCCACATACCTGGAGGCTGACGTTGCCAAACCAGCCAGGGAACCAACCTGGGAAGTGGCCAGAACTGCCTGGGGTCCAAGAACTCTTGTGCCTCCGTCCATCACCATG
TGGGTTTTGAAGACCCTCGACTGCCTCCCCGATGCTCCGAAGCCTGATCTTCCAGGGTGGGGAGGAGAAAATCCCACCTCCCCTGACCTCCACCACCTCCACCACCACCACCACCACCACCACCACCA
CTACCACCACCACCCAACTGGGGCTAGAGTGGGGAAGATTTCCCCTTTAGATCAAACTGCCCCTTCCATGGAAAAGCTGGAAAAAAACTCTGGAACCCATATCCAGGCTTGGTGAGGTTGCTGCCAAC
AGTCCTGGCCTCCCCCATCCCTAGGCTAAAGAGCCATGAGTCCTGGAGGAGGAGAGGACCCCTCCCAAAGGACTGGAGACAAAACCCTCTGCTTCCTTGGGTCCCTCCAAGACTCCCTGGGGCCCAAC
TGTGTTGCTCCACCCGGACCCATCTCTCCCTTCTAGACCTGAGCTTGCCCCTCCAGCTAGCACTAAGCAACATCTCGCTGTGGACGCCTGTAAATTACTGAGAAATGTGAAACGTGCAATCTTGAAAC
TGAGGTGTTAGAAAACTTGATCTGTGGTGTTTTGTTTTGTTTTTTTTCTTAAAACAACAGCAACGTGATCTTGGCTGTCTGTCATGTGTTGAAGTCCATGGTTGGGTCTTGTGAAGTCTGAGGTTTAA
CAGTTTGTTGTCCTGGAGGGATTTTCTTACAGCGAAGACTTGAGTTCCTCCAAGTCCCAGAACCCCAAGAATGGGCAAGAAGGATCAGGTCAGCCACTCCCTGGAGACACAGCCTTCTGGCTGGGACT
GACTTGGCCATGTTCTCAGCTGAGCCACGCGGCTGGTAGTGCAGCCTTCTGTGACCCCGCTGTGGTAAGTCCAGCCTGCCCAGGGCTGCTGAGGGCTGCCTCTTGACAGTGCAGTCTTATCGAGACCC
AATGCCTCAGTCTGCTCATCCGTAAAGTGGGGATAGTGAAGATGACACCCCTCCCCACCACCTCTCATAAGCACTTTAGGAACACACAGAGGGTAGGGATAGTGGCCCTGGCCGTCTATCCTACCCCT
TTAGTGACCGCCCCCATCCCGGCTTTCTGAGCTGATCCTTGAAGAAGAAATCTTCCATTTCTGCTCTCAAACCCTACTGGGATCAAACTGGAATAAATTGAAGACAGCCAGGGGGATGGTGCAGCTGT
GAAGCTCGGGCTGATTCCCCCTCTGTCCCAGAAGGTTGGCCAGAGGGTGTGACCCAGTTACCCTTTAACCCCCACCCTTCCAGTCGGGTGTGAGGGCCTGACCGGGCCCAGGGCAAGCAGATGTCGCA
AGCCCTATTTATTCAGTCTTCACTATAACTCTTAGAGTTGAGACGCTAATGTTCATGACTCCTGGCCTTGGGATGCCCAAGGGATTTCTGGCTCAGGCTGTAAAAGTAGCTGAGCCATCCTGCCCATT
CCTGGAGGTCCTACAGGTGAAACTGCAGGAGCTCAGCATAGACCCAGCTCTCTGGGGGATGGTCACCTGGTGATTTCAATGATGGCATCCAGGAATTAGCTGAGCCAACAGACCATGTGGACAGCTTT
GGCCAGAGCTCCCGTGTGGCATCTGGGAGCCACAGTGACCCAGCCACCTGGCTCAGGCTAGTTCCAAATTCCAAAAGATTGGCTTGTAAACCTTCGTCTCCCTCTCTTTTACCCAGAGACAGCACATA
CGTGTGCACACGCATGCACACACACATTCAGTATTTTAAAAGAATGTTTTCTTGGTGCCATTTTCATTTTATTTTATTTTTTAATTCTTGGAGGGGGAAATAAGGGAATAAGGCCAAGGAAGATGTAT
AGCTTTAGCTTTAGCCTGGCAACCTGGAGAATCCACATACCTTGTGTATTGAACCCCAGGAAAAGGAAGAGGTCGAACCAACCCTGCGGAAGGAGCATGGTTTCAGGAGTTTATTTTAAGACTGCTGG
GAAGGAAACAGGCCCCATTTTGTATATAGTTGCAACTTAAACTTTTTGGCTTGCAAAATATTTTTGTAATAAAGATTTCTGGGTAATAATGAG

hide sequence

RefSeq Acc Id:

XM_024451836 ⟹ XP_024307604

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,936 - 1,940,592 (+)	NCBI

Sequence:

show sequence

TGTGGAGCCCGGGCGGGGCAGCCGCGGCCCATGGAGCCCGCCGGCCCGGCCCCCGGCCGCCTCGGGCCGCTGCTCTGCCTGCTGCTCGCCGCGTCCTGCGCCTGGTCAGGAGTGGCGGGTGAGGAGGA
GCTGCAGGTGATTCAGCCTGACAAGTCCGTGTTGGTTGCAGCTGGAGAGACAGCCACTCTGCGCTGCACTGCGACCTCTCTGATCCCTGTGGGGCCCATCCAGTGGTTCAGAGGAGCTGGACCAGGCC
GGGAATTAATCTACAATCAAAAAGAAGGCCACTTCCCCCGGGTAACAACTGTTTCAGACCTCACAAAGAGAAACAACATGGACTTTTCCATCCGCATCGGTAACATCACCCCAGCAGATGCCGGCACC
TACTACTGTGTGAAGTTCCGGAAAGGGAGCCCCGATGACGTGGAGTTTAAGTCTGGAGCAGGCACTGAGCTGTCTGTGCGCGCCAAACCCTCTGCCCCCGTGGTATCGGGCCCTGCGGCGAGGGCCAC
ACCTCAGCACACAGTGAGCTTCACCTGCGAGTCCCACGGCTTCTCACCCAGAGACATCACCCTGAAATGGTTCAAAAATGGGAATGAGCTCTCAGACTTCCAGACCAACGTGGACCCCGTAGGAGAGA
GCGTGTCCTACAGCATCCACAGCACAGCCAAGGTGGTGCTGACCCGCGAGGACGTTCACTCTCAAGTCATCTGCGAGGTGGCCCACGTCACCTTGCAGGGGGACCCTCTTCGTGGGACTGCCAACTTG
TCTGAGACCATCCGAGTTCCACCCACCTTGGAGGTTACTCAACAGCCCGTGAGGGCAGAGAACCAGGTGAATGTCACCTGCCAGGTGAGGAAGTTCTACCCCCAGAGACTACAGCTGACCTGGTTGGA
GAATGGAAACGTGTCCCGGACAGAAACGGCCTCAACCGTTACAGAGAACAAGGATGGTACCTACAACTGGATGAGCTGGCTCCTGGTGAATGTATCTGCCCACAGGGATGATGTGAAGCTCACCTGCC
AGGTGGAGCATGACGGGCAGCCAGCGGTCAGCAAAAGCCATGACCTGAAGGTCTCAGCCCACCCGAAGGAGCAGGGCTCAAATACCGCCGCTGAGAACACTGGATCTAATGAACGGAACATCTATATT
GTGGTGGGTGTGGTGTGCACCTTGCTGGTGGCCCTACTGATGGCGGCCCTCTACCTCGTCCGAATCAGACAGAAGAAAGCCCAGGGCTCCACTTCTTCTACAAGGTTGCATGAGCCCGAGAAGAATGC
CAGAGAAATAACACAGGTACAGTCCTTGGACACAAATGATATCACATATGCAGACCTGAACCTGCCCAAGGGGAAGAAGCCTGCTCCCCAGGCTGCGGAGCCCAACAACCACACGGAGTATGCCAGCA
TTCAGACCAGCCCGCAGCCCGCGTCGGAGGACACCCTCACCTATGCTGACCTGGACATGGTCCACCTCAACCGGACCCCCAAGCAGCCGGCCCCCAAGCCTGAGCCGTCCTTCTCAGAGTACGCCAGC
GTCCAGGTCCCGAGGAAGTGAATGGGACCGTGGTTTGCTCTAGCACCCATCTCTACGCGCTTTCTTGTCCCACAGGGAGCCGCCGTGATGAGCACAGCCAACCCAGTTCCCGGAGGGCTGGGGCGGTG
CAGGCTCTGGGACCCAGGGGCCAGGGTGGCTCTTCTCTCCCCACCCCTCCTTGGCTCTCCAGCACTTCCTGGGCAGCCACGGCCCCCTCCCCCCACATTGCCACATACCTGGAGGCTGACGTTGCCAA
ACCAGCCAGGGAACCAACCTGGGAAGTGGCCAGAACTGCCTGGGGTCCAAGAACTCTTGTGCCTCCGTCCATCACCATGTGGGTTTTGAAGACCCTCGACTGCCTCCCCGATGCTCCGAAGCCTGATC
TTCCAGGGTGGGGAGGAGAAAATCCCACCTCCCCTGACCTCCACCACCTCCACCACCACCACCACCACCACCACCACCACTACCACCACCACCCAACTGGGGCTAGAGTGGGGAAGATTTCCCCTTTA
GATCAAACTGCCCCTTCCATGGAAAAGCTGGAAAAAAACTCTGGAACCCATATCCAGGCTTGGTGAGGTTGCTGCCAACAGTCCTGGCCTCCCCCATCCCTAGGCTAAAGAGCCATGAGTCCTGGAGG
AGGAGAGGACCCCTCCCAAAGGACTGGAGACAAAACCCTCTGCTTCCTTGGGTCCCTCCAAGACTCCCTGGGGCCCAACTGTGTTGCTCCACCCGGACCCATCTCTCCCTTCTAGACCTGAGCTTGCC
CCTCCAGCTAGCACTAAGCAACATCTCGCTGTGGACGCCTGTAAATTACTGAGAAATGTGAAACGTGCAATCTTGAAACTGAGGTGTTAGAAAACTTGATCTGTGGTGTTTTGTTTTGTTTTTTTTCT
TAAAACAACAGCAACGTGATCTTGGCTGTCTGTCATGTGTTGAAGTCCATGGTTGGGTCTTGTGAAGTCTGAGGTTTAACAGTTTGTTGTCCTGGAGGGATTTTCTTACAGCGAAGACTTGAGTTCCT
CCAAGTCCCAGAACCCCAAGAATGGGCAAGAAGGATCAGGTCAGCCACTCCCTGGAGACACAGCCTTCTGGCTGGGACTGACTTGGCCATGTTCTCAGCTGAGCCACGCGGCTGGTAGTGCAGCCTTC
TGTGACCCCGCTGTGGTAAGTCCAGCCTGCCCAGGGCTGCTGAGGGCTGCCTCTTGACAGTGCAGTCTTATCGAGACCCAATGCCTCAGTCTGCTCATCCGTAAAGTGGGGATAGTGAAGATGACACC
CCTCCCCACCACCTCTCATAAGCACTTTAGGAACACACAGAGGGTAGGGATAGTGGCCCTGGCCGTCTATCCTACCCCTTTAGTGACCGCCCCCATCCCGGCTTTCTGAGCTGATCCTTGAAGAAGAA
ATCTTCCATTTCTGCTCTCAAACCCTACTGGGATCAAACTGGAATAAATTGAAGACAGCCAGGGGGATGGTGCAGCTGTGAAGCTCGGGCTGATTCCCCCTCTGTCCCAGAAGGTTGGCCAGAGGGTG
TGACCCAGTTACCCTTTAACCCCCACCCTTCCAGTCGGGTGTGAGGGCCTGACCGGGCCCAGGGCAAGCAGATGTCGCAAGCCCTATTTATTCAGTCTTCACTATAACTCTTAGAGTTGAGACGCTAA
TGTTCATGACTCCTGGCCTTGGGATGCCCAAGGGATTTCTGGCTCAGGCTGTAAAAGTAGCTGAGCCATCCTGCCCATTCCTGGAGGTCCTACAGGTGAAACTGCAGGAGCTCAGCATAGACCCAGCT
CTCTGGGGGATGGTCACCTGGTGATTTCAATGATGGCATCCAGGAATTAGCTGAGCCAACAGACCATGTGGACAGCTTTGGCCAGAGCTCCCGTGTGGCATCTGGGAGCCACAGTGACCCAGCCACCT
GGCTCAGGCTAGTTCCAAATTCCAAAAGATTGGCTTGTAAACCTTCGTCTCCCTCTCTTTTACCCAGAGACAGCACATACGTGTGCACACGCATGCACACACACATTCAGTATTTTAAAAGAATGTTT
TCTTGGTGCCATTTTCATTTTATTTTATTTTTTAATTCTTGGAGGGGGAAATAAGGGAATAAGGCCAAGGAAGATGTATAGCTTTAGCTTTAGCCTGGCAACCTGGAGAATCCACATACCTTGTGTAT
TGAACCCCAGGAAAAGGAAGAGGTCGAACCAACCCTGCGGAAGGAGCATGGTTTCAGGAGTTTATTTTAAGACTGCTGGGAAGGAAACAGGCCCCATTTTGTATATAGTTGCAACTTAAACTTTTTGG
CTTGCAAAATATTTTTGTAATAAAGATTTCTGGGTAATAATGAG

hide sequence

RefSeq Acc Id:

XM_047439915 ⟹ XP_047295871

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,895,407 - 1,940,592 (+)	NCBI

RefSeq Acc Id:

XM_047439916 ⟹ XP_047295872

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,936 - 1,940,592 (+)	NCBI

RefSeq Acc Id:

XM_047439917 ⟹ XP_047295873

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,167 - 1,940,592 (+)	NCBI

RefSeq Acc Id:

XM_047439918 ⟹ XP_047295874

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,936 - 1,940,592 (+)	NCBI

RefSeq Acc Id:

XM_047439919 ⟹ XP_047295875

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,167 - 1,940,592 (+)	NCBI

RefSeq Acc Id:

XM_047439920 ⟹ XP_047295876

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,936 - 1,940,592 (+)	NCBI

RefSeq Acc Id:

XM_054323047 ⟹ XP_054179022

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	20	1,924,933 - 1,970,769 (+)	NCBI

RefSeq Acc Id:

XM_054323048 ⟹ XP_054179023

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	20	1,925,091 - 1,970,769 (+)	NCBI

RefSeq Acc Id:

XM_054323049 ⟹ XP_054179024

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	20	1,944,468 - 1,970,769 (+)	NCBI

RefSeq Acc Id:

XM_054323050 ⟹ XP_054179025

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	20	1,925,103 - 1,970,769 (+)	NCBI

RefSeq Acc Id:

XM_054323051 ⟹ XP_054179026

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	20	1,924,358 - 1,970,769 (+)	NCBI

RefSeq Acc Id:

XM_054323052 ⟹ XP_054179027

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	20	1,925,081 - 1,970,769 (+)	NCBI

RefSeq Acc Id:

XM_054323053 ⟹ XP_054179028

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	20	1,924,358 - 1,970,769 (+)	NCBI

RefSeq Acc Id:

XM_054323054 ⟹ XP_054179029

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	20	1,925,103 - 1,970,769 (+)	NCBI


Protein RefSeqs	NP_001035111	(Get FASTA)	NCBI Sequence Viewer
	NP_001035112	(Get FASTA)	NCBI Sequence Viewer
	NP_001317657	(Get FASTA)	NCBI Sequence Viewer
	NP_542970	(Get FASTA)	NCBI Sequence Viewer
	XP_005260727	(Get FASTA)	NCBI Sequence Viewer
	XP_011527475	(Get FASTA)	NCBI Sequence Viewer
	XP_024307604	(Get FASTA)	NCBI Sequence Viewer
	XP_047295871	(Get FASTA)	NCBI Sequence Viewer
	XP_047295872	(Get FASTA)	NCBI Sequence Viewer
	XP_047295873	(Get FASTA)	NCBI Sequence Viewer
	XP_047295874	(Get FASTA)	NCBI Sequence Viewer
	XP_047295875	(Get FASTA)	NCBI Sequence Viewer
	XP_047295876	(Get FASTA)	NCBI Sequence Viewer
	XP_054179022	(Get FASTA)	NCBI Sequence Viewer
	XP_054179023	(Get FASTA)	NCBI Sequence Viewer
	XP_054179024	(Get FASTA)	NCBI Sequence Viewer
	XP_054179025	(Get FASTA)	NCBI Sequence Viewer
	XP_054179026	(Get FASTA)	NCBI Sequence Viewer
	XP_054179027	(Get FASTA)	NCBI Sequence Viewer
	XP_054179028	(Get FASTA)	NCBI Sequence Viewer
	XP_054179029	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAH26692	(Get FASTA)	NCBI Sequence Viewer
	AAH33092	(Get FASTA)	NCBI Sequence Viewer
	AAH38510	(Get FASTA)	NCBI Sequence Viewer
	AAH75849	(Get FASTA)	NCBI Sequence Viewer
	BAA12974	(Get FASTA)	NCBI Sequence Viewer
	BAA87929	(Get FASTA)	NCBI Sequence Viewer
	BAF83465	(Get FASTA)	NCBI Sequence Viewer
	BAG35420	(Get FASTA)	NCBI Sequence Viewer
	BAG60509	(Get FASTA)	NCBI Sequence Viewer
	CAA71403	(Get FASTA)	NCBI Sequence Viewer
	CAA71944	(Get FASTA)	NCBI Sequence Viewer
	EAX10606	(Get FASTA)	NCBI Sequence Viewer
	EAX10607	(Get FASTA)	NCBI Sequence Viewer
	EAX10608	(Get FASTA)	NCBI Sequence Viewer
	EAX10609	(Get FASTA)	NCBI Sequence Viewer
	EAX10610	(Get FASTA)	NCBI Sequence Viewer
	EAX10611	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000348307
	ENSP00000348307.3
	ENSP00000351621
	ENSP00000351621.4
	ENSP00000382941
	ENSP00000382941.4
	ENSP00000478763
	ENSP00000478763.1
GenBank Protein	P78324	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_001035111 ⟸ NM_001040022
- Peptide Label:	isoform 1 precursor
- UniProtKB:	Q9Y4U9 (UniProtKB/Swiss-Prot), Q9UIJ6 (UniProtKB/Swiss-Prot), Q9UDX2 (UniProtKB/Swiss-Prot), Q9H0Z2 (UniProtKB/Swiss-Prot), Q8TAL8 (UniProtKB/Swiss-Prot), Q8N517 (UniProtKB/Swiss-Prot), A2A2E1 (UniProtKB/Swiss-Prot), P78324 (UniProtKB/Swiss-Prot), O43799 (UniProtKB/Swiss-Prot), O00683 (UniProtKB/Swiss-Prot), B2R6C3 (UniProtKB/Swiss-Prot), A8K411 (UniProtKB/Swiss-Prot), B4DP97 (UniProtKB/TrEMBL)
- Sequence:	show sequence MEPAGPAPGRLGPLLCLLLAASCAWSGVAGEEELQVIQPDKSVLVAAGETATLRCTATSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRIGNITPADAGTYYCVKFRKGS PDDVEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTL EVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSAHPKEQGSNTAAENTGSNERNIYIVVGVVCTLLV ALLMAALYLVRIRQKKAQGSTSSTRLHEPEKNAREITQDTNDITYADLNLPKGKKPAPQAAEPNNHTEYASIQTSPQPASEDTLTYADLDMVHLNRTPKQPAPKPEPSFSEYASVQVPRK hide sequence

RefSeq Acc Id:	NP_001035112 ⟸ NM_001040023
- Peptide Label:	isoform 1 precursor
- UniProtKB:	Q9Y4U9 (UniProtKB/Swiss-Prot), Q9UIJ6 (UniProtKB/Swiss-Prot), Q9UDX2 (UniProtKB/Swiss-Prot), Q9H0Z2 (UniProtKB/Swiss-Prot), Q8TAL8 (UniProtKB/Swiss-Prot), Q8N517 (UniProtKB/Swiss-Prot), P78324 (UniProtKB/Swiss-Prot), O43799 (UniProtKB/Swiss-Prot), O00683 (UniProtKB/Swiss-Prot), B2R6C3 (UniProtKB/Swiss-Prot), A8K411 (UniProtKB/Swiss-Prot), A2A2E1 (UniProtKB/Swiss-Prot), B4DP97 (UniProtKB/TrEMBL)
- Sequence:	show sequence MEPAGPAPGRLGPLLCLLLAASCAWSGVAGEEELQVIQPDKSVLVAAGETATLRCTATSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRIGNITPADAGTYYCVKFRKGS PDDVEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTL EVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSAHPKEQGSNTAAENTGSNERNIYIVVGVVCTLLV ALLMAALYLVRIRQKKAQGSTSSTRLHEPEKNAREITQDTNDITYADLNLPKGKKPAPQAAEPNNHTEYASIQTSPQPASEDTLTYADLDMVHLNRTPKQPAPKPEPSFSEYASVQVPRK hide sequence

RefSeq Acc Id:	NP_542970 ⟸ NM_080792
- Peptide Label:	isoform 1 precursor
- UniProtKB:	Q9Y4U9 (UniProtKB/Swiss-Prot), Q9UIJ6 (UniProtKB/Swiss-Prot), Q9UDX2 (UniProtKB/Swiss-Prot), Q9H0Z2 (UniProtKB/Swiss-Prot), Q8TAL8 (UniProtKB/Swiss-Prot), Q8N517 (UniProtKB/Swiss-Prot), P78324 (UniProtKB/Swiss-Prot), O43799 (UniProtKB/Swiss-Prot), O00683 (UniProtKB/Swiss-Prot), B2R6C3 (UniProtKB/Swiss-Prot), A8K411 (UniProtKB/Swiss-Prot), A2A2E1 (UniProtKB/Swiss-Prot), B4DP97 (UniProtKB/TrEMBL)
- Sequence:	show sequence MEPAGPAPGRLGPLLCLLLAASCAWSGVAGEEELQVIQPDKSVLVAAGETATLRCTATSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRIGNITPADAGTYYCVKFRKGS PDDVEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTL EVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSAHPKEQGSNTAAENTGSNERNIYIVVGVVCTLLV ALLMAALYLVRIRQKKAQGSTSSTRLHEPEKNAREITQDTNDITYADLNLPKGKKPAPQAAEPNNHTEYASIQTSPQPASEDTLTYADLDMVHLNRTPKQPAPKPEPSFSEYASVQVPRK hide sequence

RefSeq Acc Id:	XP_005260727 ⟸ XM_005260670
- Peptide Label:	isoform X1
- UniProtKB:	B4DP97 (UniProtKB/TrEMBL)
- Sequence:	show sequence MEPAGPAPGRLGPLLCLLLAASCAWSGVAGEEELQVIQPDKSVLVAAGETATLRCTATSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRIGNITPADAGTYYCVKFRKGS PDDVEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTL EVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSAHPKEQGSNTAAENTGSNERNIYIVVGVVCTLLV ALLMAALYLVRIRQKKAQGSTSSTRLHEPEKNAREITQVQSLDTNDITYADLNLPKGKKPAPQAAEPNNHTEYASIQTSPQPASEDTLTYADLDMVHLNRTPKQPAPKPEPSFSEYASVQVPRK hide sequence

RefSeq Acc Id:	XP_011527475 ⟸ XM_011529173
- Peptide Label:	isoform X2
- UniProtKB:	B4DP97 (UniProtKB/TrEMBL)
- Sequence:	show sequence MTLKTRCCIWTLSPALAYFILPEIHRGVAGEEELQVIQPDKSVLVAAGETATLRCTATSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRIGNITPADAGTYYCVKFRKGS PDDVEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTL EVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSAHPKEQGSNTAAENTGSNERNIYIVVGVVCTLLV ALLMAALYLVRIRQKKAQGSTSSTRLHEPEKNAREITQVQSLDTNDITYADLNLPKGKKPAPQAAEPNNHTEYASIQTSPQPASEDTLTYADLDMVHLNRTPKQPAPKPEPSFSEYASVQVPRK hide sequence

Protein Domains

Ig-like Ig-like C1-type Ig-like V-type

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-P78324-F1-model_v2	AlphaFold	P78324	1-504	view protein structure

RGD ID:

6799053

Promoter ID:

HG_KWN:38357

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

Lymphoblastoid, NB4

Transcripts:

ENST00000358771, NM_001040022, OTTHUMT00000251762, OTTHUMT00000251763, UC002WFT.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	20	1,823,274 - 1,823,774 (+)	MPROMDB

RGD ID:

13206149

Promoter ID:

EPDNEW_H26655

Type:

initiation region

Name:

SIRPA_2

Description:

signal regulatory protein alpha

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H26656 EPDNEW_H26657 EPDNEW_H26658

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,117 - 1,894,177	EPDNEW

RGD ID:

13206151

Promoter ID:

EPDNEW_H26656

Type:

initiation region

Name:

SIRPA_1

Description:

signal regulatory protein alpha

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H26655 EPDNEW_H26657 EPDNEW_H26658

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,488 - 1,894,548	EPDNEW

RGD ID:

13206153

Promoter ID:

EPDNEW_H26657

Type:

initiation region

Name:

SIRPA_4

Description:

signal regulatory protein alpha

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H26655 EPDNEW_H26656 EPDNEW_H26658

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,894,708 - 1,894,768	EPDNEW

RGD ID:

13206155

Promoter ID:

EPDNEW_H26658

Type:

initiation region

Name:

SIRPA_3

Description:

signal regulatory protein alpha

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H26655 EPDNEW_H26656 EPDNEW_H26657

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	1,895,379 - 1,895,439	EPDNEW

Database	Acc Id	Source(s)
COSMIC	SIRPA	COSMIC
Ensembl Genes	ENSG00000198053	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000356025	ENTREZGENE
	ENST00000356025.7	UniProtKB/Swiss-Prot
	ENST00000358771	ENTREZGENE
	ENST00000358771.5	UniProtKB/Swiss-Prot
	ENST00000400068	ENTREZGENE
	ENST00000400068.7	UniProtKB/Swiss-Prot
	ENST00000622179	ENTREZGENE
	ENST00000622179.4	UniProtKB/Swiss-Prot
Gene3D-CATH	2.60.40.10	UniProtKB/Swiss-Prot
GTEx	ENSG00000198053	GTEx
HGNC ID	HGNC:9662	ENTREZGENE
Human Proteome Map	SIRPA	Human Proteome Map
InterPro	Ig-like_CS_Receptor	UniProtKB/Swiss-Prot
	Ig-like_dom	UniProtKB/Swiss-Prot
	Ig-like_dom_sf	UniProtKB/Swiss-Prot
	Ig-like_fold	UniProtKB/Swiss-Prot
	Ig_C1-set	UniProtKB/Swiss-Prot
	Ig_sub	UniProtKB/Swiss-Prot
	Ig_V-set	UniProtKB/Swiss-Prot
KEGG Report	hsa:140885	UniProtKB/Swiss-Prot
NCBI Gene	SIRPA	ENTREZGENE
OMIM	602461	OMIM
PANTHER	SIGNAL-REGULATORY PROTEIN BETA	UniProtKB/Swiss-Prot
Pfam	C1-set	UniProtKB/Swiss-Prot
	V-set	UniProtKB/Swiss-Prot
PharmGKB	PA34006	PharmGKB
PROSITE	IG_LIKE	UniProtKB/Swiss-Prot
SMART	IGc1	UniProtKB/Swiss-Prot
	IGv	UniProtKB/Swiss-Prot
	SM00409	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF48726	UniProtKB/Swiss-Prot
UniProt	A2A2E1	ENTREZGENE
	A8K411	ENTREZGENE
	B2R6C3	ENTREZGENE
	B4DP97	ENTREZGENE, UniProtKB/TrEMBL
	O00683	ENTREZGENE
	O43799	ENTREZGENE
	P78324	ENTREZGENE
	Q8N517	ENTREZGENE
	Q8TAL8	ENTREZGENE
	Q9H0Z2	ENTREZGENE
	Q9UDX2	ENTREZGENE
	Q9UIJ6	ENTREZGENE
	Q9Y4U9	ENTREZGENE
	SHPS1_HUMAN	UniProtKB/Swiss-Prot
UniProt Secondary	A2A2E1	UniProtKB/Swiss-Prot
	A8K411	UniProtKB/Swiss-Prot
	B2R6C3	UniProtKB/Swiss-Prot
	O00683	UniProtKB/Swiss-Prot
	O43799	UniProtKB/Swiss-Prot
	Q8N517	UniProtKB/Swiss-Prot
	Q8TAL8	UniProtKB/Swiss-Prot
	Q9H0Z2	UniProtKB/Swiss-Prot
	Q9UDX2	UniProtKB/Swiss-Prot
	Q9UIJ6	UniProtKB/Swiss-Prot
	Q9Y4U9	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2016-01-26	SIRPA	signal regulatory protein alpha	SIRPA	signal-regulatory protein alpha	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message

Imported Disease Annotations - CTD